
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | (Registrant’s telephone number, including area code) | |||||||||||||||||||||
(Address of principal executive offices, including Zip Code) | |||||||||||||||||||||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.875% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.250% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 6.500% | ||||||||
Depositary Shares, each representing 1/1,000th interest in a share of 6.625% | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||||||||||||||||||||||
| Table of Contents | Part | Item | Page | |||||||||||
| I | ||||||||||||||
| I | 2 | |||||||||||||
| I | 3 | |||||||||||||
| I | 1 | |||||||||||||
Consolidated Balance Sheet (Unaudited at March 31, 2025) | ||||||||||||||
| I | 4 | |||||||||||||
| II | ||||||||||||||
| II | 1 | |||||||||||||
| II | 1A | |||||||||||||
| II | 2 | |||||||||||||
| II | 5 | |||||||||||||
| II | 6 | |||||||||||||
2 | ||||||||
3 | ||||||||
4 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||




| March 2025 Form 10-Q | 5 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||


6 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||

| Three Months Ended March 31, | ||||||||
$ in millions, except per share data | 2025 | 2024 | ||||||
| Consolidated results | ||||||||
| Net revenues | $ | 17,739 | $ | 15,136 | ||||
| Earnings applicable to Morgan Stanley common shareholders | $ | 4,157 | $ | 3,266 | ||||
| Earnings per diluted common share | $ | 2.60 | $ | 2.02 | ||||
| Consolidated financial measures | ||||||||
Expense efficiency ratio1 | 68 | % | 71 | % | ||||
ROE2 | 17.4 | % | 14.5 | % | ||||
ROTCE2, 3 | 23.0 | % | 19.7 | % | ||||
Pre-tax margin4 | 31 | % | 29 | % | ||||
| Effective tax rate | 21.2 | % | 21.2 | % | ||||
Pre-tax margin by segment4 | ||||||||
| Institutional Securities | 37 | % | 34 | % | ||||
| Wealth Management | 27 | % | 26 | % | ||||
| Investment Management | 20 | % | 18 | % | ||||
$ in millions, except per share data, worldwide employees and client assets | At March 31, 2025 | At December 31, 2024 | ||||||
Average liquidity resources for three months ended5 | $ | 351,740 | $ | 345,440 | ||||
Loans6 | $ | 258,969 | $ | 246,814 | ||||
| Total assets | $ | 1,300,296 | $ | 1,215,071 | ||||
| Deposits | $ | 381,563 | $ | 376,007 | ||||
| Borrowings | $ | 305,390 | $ | 288,819 | ||||
Common equity | $ | 97,062 | $ | 94,761 | ||||
Tangible common equity3 | $ | 74,044 | $ | 71,604 | ||||
| Common shares outstanding | 1,607 | 1,607 | ||||||
Book value per common share7 | $ | 60.41 | $ | 58.98 | ||||
Tangible book value per common share3, 7 | $ | 46.08 | $ | 44.57 | ||||
| Worldwide employees (in thousands) | 81 | 80 | ||||||
Client assets8 (in billions) | $ | 7,662 | $ | 7,860 | ||||
Capital Ratios9 | ||||||||
| Common Equity Tier 1 capital—Standardized | 15.3 | % | 15.9 | % | ||||
| Tier 1 capital—Standardized | 17.2 | % | 18.0 | % | ||||
| Common Equity Tier 1 capital—Advanced | 15.7 | % | 15.7 | % | ||||
| Tier 1 capital—Advanced | 17.7 | % | 17.8 | % | ||||
| Tier 1 leverage | 6.9 | % | 6.9 | % | ||||
| SLR | 5.6 | % | 5.6 | % | ||||
| March 2025 Form 10-Q | 7 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Net revenues | $ | 17,739 | $ | 15,136 | ||||
Adjustment for mark-to-market losses (gains) on DCP1 | 149 | (187) | ||||||
| Adjusted Net revenues—non-GAAP | $ | 17,888 | $ | 14,949 | ||||
| Compensation expense | $ | 7,521 | $ | 6,696 | ||||
Adjustment for mark-to-market gains (losses) on DCP1 | 2 | (249) | ||||||
| Adjusted Compensation expense—non-GAAP | $ | 7,523 | $ | 6,447 | ||||
| Wealth Management Net revenues | $ | 7,327 | $ | 6,880 | ||||
Adjustment for mark-to-market losses (gains) on DCP1 | 131 | (140) | ||||||
| Adjusted Wealth Management Net revenues—non-GAAP | $ | 7,458 | $ | 6,740 | ||||
| Wealth Management Compensation expense | $ | 3,999 | $ | 3,788 | ||||
Adjustment for mark-to-market gains (losses) on DCP1 | 17 | (156) | ||||||
| Adjusted Wealth Management Compensation expense—non-GAAP | $ | 4,016 | $ | 3,632 | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Tangible equity | ||||||||
Common equity | $ | 97,062 | $ | 94,761 | ||||
| Less: Goodwill and net intangible assets | (23,018) | (23,157) | ||||||
Tangible common equity—non-GAAP | $ | 74,044 | $ | 71,604 | ||||
8 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Monthly Balance | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Tangible equity | ||||||||
Common equity | $ | 95,488 | $ | 89,913 | ||||
| Less: Goodwill and net intangible assets | (23,083) | (23,705) | ||||||
Tangible common equity—non-GAAP | $ | 72,405 | $ | 66,208 | ||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2025 | 2024 | ||||||
Average common equity1 | ||||||||
| Institutional Securities | $ | 48.4 | $ | 45.0 | ||||
| Wealth Management | 29.4 | 29.1 | ||||||
| Investment Management | 10.6 | 10.8 | ||||||
ROE2 | ||||||||
| Institutional Securities | 20 | % | 15 | % | ||||
| Wealth Management | 20 | % | 19 | % | ||||
| Investment Management | 10 | % | 7 | % | ||||
Average tangible common equity1 | ||||||||
| Institutional Securities | $ | 48.0 | $ | 44.6 | ||||
| Wealth Management | 16.3 | 15.5 | ||||||
| Investment Management | 1.0 | 1.1 | ||||||
ROTCE2 | ||||||||
| Institutional Securities | 20 | % | 15 | % | ||||
| Wealth Management | 37 | % | 35 | % | ||||
| Investment Management | 104 | % | 68 | % | ||||
| March 2025 Form 10-Q | 9 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2025 | 2024 | |||||||||
| Revenues | |||||||||||
| Advisory | $ | 563 | $ | 461 | 22 | % | |||||
| Equity | 319 | 430 | (26) | % | |||||||
| Fixed Income | 677 | 556 | 22 | % | |||||||
| Total Underwriting | 996 | 986 | 1 | % | |||||||
Total Investment Banking | 1,559 | 1,447 | 8 | % | |||||||
| Equity | 4,128 | 2,842 | 45 | % | |||||||
Fixed Income | 2,604 | 2,485 | 5 | % | |||||||
| Other | 692 | 242 | 186 | % | |||||||
| Net revenues | 8,983 | 7,016 | 28 | % | |||||||
| Provision for credit losses | 91 | 2 | N/M | ||||||||
| Compensation and benefits | 2,854 | 2,343 | 22 | % | |||||||
| Non-compensation expenses | 2,757 | 2,320 | 19 | % | |||||||
| Total non-interest expenses | 5,611 | 4,663 | 20 | % | |||||||
| Income before provision for income taxes | 3,281 | 2,351 | 40 | % | |||||||
| Provision for income taxes | 696 | 482 | 44 | % | |||||||
| Net income | 2,585 | 1,869 | 38 | % | |||||||
| Net income applicable to noncontrolling interests | 56 | 50 | 12 | % | |||||||
| Net income applicable to Morgan Stanley | $ | 2,529 | $ | 1,819 | 39 | % | |||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2025 | 2024 | ||||||
Completed mergers and acquisitions1 | $ | 140 | $ | 116 | ||||
Equity and equity-related offerings2, 3 | 13 | 17 | ||||||
Fixed Income offerings2, 4 | 98 | 98 | ||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
Net Interest2 | All Other3 | ||||||||||||||||
| $ in millions | Trading | Fees1 | Total | ||||||||||||||
| Financing | $ | 2,267 | $ | 156 | $ | (596) | $ | 1 | $ | 1,828 | |||||||
| Execution services | 1,469 | 798 | (98) | 131 | 2,300 | ||||||||||||
| Total Equity | $ | 3,736 | $ | 954 | $ | (694) | $ | 132 | $ | 4,128 | |||||||
| Total Fixed Income | $ | 2,407 | $ | 107 | $ | 19 | $ | 71 | $ | 2,604 | |||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
Net Interest2 | All Other3 | ||||||||||||||||
| $ in millions | Trading | Fees1 | Total | ||||||||||||||
| Financing | $ | 2,022 | $ | 136 | $ | (891) | $ | 1 | $ | 1,268 | |||||||
| Execution services | 972 | 609 | (41) | 34 | 1,574 | ||||||||||||
| Total Equity | $ | 2,994 | $ | 745 | $ | (932) | $ | 35 | $ | 2,842 | |||||||
| Total Fixed Income | $ | 2,594 | $ | 104 | $ | (292) | $ | 79 | $ | 2,485 | |||||||
10 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| March 2025 Form 10-Q | 11 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2025 | 2024 | |||||||||
| Revenues | |||||||||||
| Asset management | $ | 4,396 | $ | 3,829 | 15 | % | |||||
Transactional1 | 873 | 1,033 | (15) | % | |||||||
| Net interest | 1,902 | 1,856 | 2 | % | |||||||
Other2 | 156 | 162 | (4) | % | |||||||
| Net revenues | 7,327 | 6,880 | 6 | % | |||||||
| Provision for credit losses | 44 | (8) | N/M | ||||||||
| Compensation and benefits | 3,999 | 3,788 | 6 | % | |||||||
| Non-compensation expenses | 1,333 | 1,294 | 3 | % | |||||||
| Total non-interest expenses | 5,332 | 5,082 | 5 | % | |||||||
Income before provision for income taxes | 1,951 | 1,806 | 8 | % | |||||||
| Provision for income taxes | 419 | 403 | 4 | % | |||||||
| Net income applicable to Morgan Stanley | $ | 1,532 | $ | 1,403 | 9 | % | |||||
| $ in billions | At March 31, 2025 | At December 31, 2024 | ||||||
Total client assets1 | $ | 6,015 | $ | 6,194 | ||||
| U.S. Bank Subsidiary loans | $ | 163 | $ | 160 | ||||
Margin and other lending2 | $ | 28 | $ | 28 | ||||
Deposits3 | $ | 375 | $ | 370 | ||||
Annualized weighted average cost of deposits4 | ||||||||
| Period end | 2.77% | 2.73% | ||||||
Period average for three months ended | 2.77% | 2.94% | ||||||
| Three Months Ended March 31, | ||||||||
| 2025 | 2024 | |||||||
Net new assets | $ | 93.8 | $ | 94.9 | ||||
| $ in billions | At March 31, 2025 | At December 31, 2024 | ||||||
Advisor-led client assets1 | $ | 4,719 | $ | 4,758 | ||||
Fee-based client assets2 | $ | 2,349 | $ | 2,347 | ||||
| Fee-based client assets as a percentage of advisor-led client assets | 50% | 49% | ||||||
| Three Months Ended March 31, | ||||||||
| 2025 | 2024 | |||||||
Fee-based asset flows3 | $ | 29.8 | $ | 26.2 | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||
Self-directed client assets1 (in billions) | $ | 1,295 | $ | 1,437 | ||||
Self-directed households2 (in millions) | 8.3 | 8.3 | ||||||
| Three Months Ended March 31, | ||||||||
| 2025 | 2024 | |||||||
Daily average revenue trades (“DARTs”)3 (in thousands) | 1,003 | 841 | ||||||
| At March 31, 2025 | At December 31, 2024 | |||||||
Stock plan unvested assets2 (in billions) | $ | 431 | $ | 475 | ||||
Stock plan participants3 (in millions) | 6.7 | 6.6 | ||||||
12 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At Dec 31, 2024 | Inflows1 | Outflows2 | Market Impact3 | At March 31, 2025 | ||||||||||||
Separately managed4 | $ | 719 | $ | 20 | $ | (12) | $ | (5) | $ | 722 | |||||||
| Unified managed | 613 | 35 | (18) | (7) | 623 | ||||||||||||
| Advisor | 207 | 9 | (11) | (4) | 201 | ||||||||||||
| Portfolio manager | 750 | 33 | (27) | (13) | 743 | ||||||||||||
| Subtotal | $ | 2,289 | $ | 97 | $ | (68) | $ | (29) | $ | 2,289 | |||||||
| Cash management | 58 | 11 | (9) | — | 60 | ||||||||||||
| Total fee-based client assets | $ | 2,347 | $ | 108 | $ | (77) | $ | (29) | $ | 2,349 | |||||||
| $ in billions | At Dec 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | At Mar 31, 2024 | ||||||||||||
Separately managed4 | $ | 589 | $ | 16 | $ | (13) | $ | 39 | $ | 631 | |||||||
| Unified managed | 501 | 31 | (14) | 27 | 545 | ||||||||||||
| Advisor | 188 | 9 | (11) | 12 | 198 | ||||||||||||
| Portfolio manager | 645 | 32 | (24) | 35 | 688 | ||||||||||||
| Subtotal | $ | 1,923 | $ | 88 | $ | (62) | $ | 113 | $ | 2,062 | |||||||
| Cash management | 60 | 12 | (10) | — | 62 | ||||||||||||
Total fee-based client assets | $ | 1,983 | $ | 100 | $ | (72) | $ | 113 | $ | 2,124 | |||||||
| March 2025 Form 10-Q | 13 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| Fee rate in bps | 2025 | 2024 | ||||||
| Separately managed | 12 | 12 | ||||||
| Unified managed | 90 | 91 | ||||||
| Advisor | 79 | 79 | ||||||
| Portfolio manager | 88 | 90 | ||||||
| Subtotal | 64 | 65 | ||||||
| Cash management | 7 | 6 | ||||||
| Total fee-based client assets | 63 | 63 | ||||||
14 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2025 | 2024 | |||||||||
| Revenues | |||||||||||
| Asset management and related fees | $ | 1,451 | $ | 1,346 | 8 | % | |||||
Performance-based income and other1 | 151 | 31 | N/M | ||||||||
| Net revenues | 1,602 | 1,377 | 16 | % | |||||||
| Compensation and benefits | 668 | 565 | 18 | % | |||||||
| Non-compensation expenses | 611 | 571 | 7 | % | |||||||
| Total non-interest expenses | 1,279 | 1,136 | 13 | % | |||||||
| Income before provision for income taxes | 323 | 241 | 34 | % | |||||||
| Provision for income taxes | 61 | 49 | 24 | % | |||||||
| Net income | 262 | 192 | 36 | % | |||||||
| Net income applicable to Morgan Stanley | $ | 262 | $ | 192 | 36 | % | |||||
| $ in billions | At Dec 31, 2024 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Mar 31, 2025 | ||||||||||||||
| Equity | $ | 312 | $ | 11 | $ | (16) | $ | (9) | $ | 3 | $ | 301 | ||||||||
Fixed Income | 192 | 18 | (13) | 3 | (1) | 199 | ||||||||||||||
| Alternatives and Solutions | 593 | 40 | (32) | (10) | — | 591 | ||||||||||||||
Long-Term AUM | $ | 1,097 | $ | 69 | $ | (61) | $ | (16) | $ | 2 | $ | 1,091 | ||||||||
| Liquidity and Overlay Services | 569 | 687 | (702) | 6 | (4) | 556 | ||||||||||||||
| Total | $ | 1,666 | $ | 756 | $ | (763) | $ | (10) | $ | (2) | $ | 1,647 | ||||||||
| $ in billions | At Dec 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Mar 31, 2024 | ||||||||||||||
| Equity | $ | 295 | $ | 11 | $ | (16) | $ | 24 | $ | (4) | $ | 310 | ||||||||
Fixed Income | 171 | 17 | (13) | 1 | (2) | 174 | ||||||||||||||
| Alternatives and Solutions | 508 | 35 | (24) | 26 | (2) | 543 | ||||||||||||||
Long-Term AUM | $ | 974 | $ | 63 | $ | (53) | $ | 51 | $ | (8) | $ | 1,027 | ||||||||
| Liquidity and Overlay Services | 485 | 522 | (531) | 6 | (4) | 478 | ||||||||||||||
| Total | $ | 1,459 | $ | 585 | $ | (584) | $ | 57 | $ | (12) | $ | 1,505 | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2025 | 2024 | ||||||
| Equity | $ | 313 | $ | 302 | ||||
| Fixed income | 197 | 172 | ||||||
| Alternatives and Solutions | 599 | 523 | ||||||
| Long-term AUM subtotal | 1,109 | 997 | ||||||
| Liquidity and Overlay Services | 560 | 482 | ||||||
| Total AUM | $ | 1,669 | $ | 1,479 | ||||
| March 2025 Form 10-Q | 15 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| Fee rate in bps | 2025 | 2024 | ||||||
| Equity | 70 | 71 | ||||||
| Fixed income | 36 | 36 | ||||||
| Alternatives and Solutions | 28 | 29 | ||||||
| Long-term AUM | 41 | 43 | ||||||
| Liquidity and Overlay Services | 13 | 13 | ||||||
| Total AUM | 32 | 33 | ||||||
16 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At March 31, 2025 | At December 31, 2024 | ||||||
| Investment securities: | ||||||||
| Available-for-sale at fair value | $ | 78.2 | $ | 76.5 | ||||
| Held-to-maturity | 47.2 | 47.8 | ||||||
| Total Investment securities | $ | 125.4 | $ | 124.3 | ||||
Wealth Management loans2 | ||||||||
| Residential real estate | $ | 67.5 | $ | 66.6 | ||||
Securities-based lending and Other3 | 95.0 | 92.9 | ||||||
Total Wealth Management loans | $ | 162.5 | $ | 159.5 | ||||
Institutional Securities loans2 | ||||||||
| Corporate | $ | 10.9 | $ | 7.1 | ||||
| Secured lending facilities | 54.0 | 50.2 | ||||||
| Commercial and Residential real estate | 11.2 | 10.5 | ||||||
| Securities-based lending and Other | 6.1 | 5.6 | ||||||
Total Institutional Securities loans | $ | 82.2 | $ | 73.4 | ||||
Total assets | $ | 442.4 | $ | 434.8 | ||||
Deposits4 | $ | 375.5 | $ | 369.7 | ||||
| March 2025 Form 10-Q | 17 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| At March 31, 2025 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 73,451 | $ | 17,204 | $ | 84 | $ | 90,739 | ||||||
| Trading assets at fair value | 385,402 | 9,614 | 5,227 | 400,243 | ||||||||||
| Investment securities | 34,722 | 123,560 | — | 158,282 | ||||||||||
| Securities purchased under agreements to resell | 94,954 | 24,094 | — | 119,048 | ||||||||||
| Securities borrowed | 139,436 | 790 | — | 140,226 | ||||||||||
| Customer and other receivables | 53,650 | 37,018 | 1,485 | 92,153 | ||||||||||
Loans1 | 86,402 | 162,497 | 4 | 248,903 | ||||||||||
Goodwill | 438 | 10,192 | 6,084 | 16,714 | ||||||||||
Intangible assets | 25 | 2,818 | 3,462 | 6,305 | ||||||||||
Other assets2 | 15,239 | 11,192 | 1,252 | 27,683 | ||||||||||
| Total assets | $ | 883,719 | $ | 398,979 | $ | 17,598 | $ | 1,300,296 | ||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 74,079 | $ | 31,072 | $ | 235 | $ | 105,386 | ||||||
| Trading assets at fair value | 320,003 | 6,915 | 4,966 | 331,884 | ||||||||||
| Investment securities | 38,096 | 121,583 | — | 159,679 | ||||||||||
| Securities purchased under agreements to resell | 100,404 | 18,161 | — | 118,565 | ||||||||||
| Securities borrowed | 121,901 | 1,958 | — | 123,859 | ||||||||||
| Customer and other receivables | 47,321 | 37,196 | 1,641 | 86,158 | ||||||||||
Loans1 | 78,607 | 159,542 | 4 | 238,153 | ||||||||||
Goodwill | 435 | 10,190 | 6,081 | 16,706 | ||||||||||
Intangible assets | 27 | 2,939 | 3,487 | 6,453 | ||||||||||
Other assets2 | 15,735 | 11,292 | 1,201 | 28,228 | ||||||||||
| Total assets | $ | 796,608 | $ | 400,848 | $ | 17,615 | $ | 1,215,071 | ||||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2025 | December 31, 2024 | ||||||
| Cash deposits with central banks | $ | 58,279 | $ | 58,493 | ||||
Unencumbered HQLA Securities1: | ||||||||
| U.S. government obligations | 167,173 | 161,952 | ||||||
| U.S. agency and agency mortgage-backed securities | 92,728 | 94,512 | ||||||
Non-U.S. sovereign obligations2 | 26,132 | 22,646 | ||||||
| Other investment grade securities | 182 | 600 | ||||||
Total HQLA1 | $ | 344,494 | $ | 338,203 | ||||
| Cash deposits with banks (non-HQLA) | 7,246 | 7,237 | ||||||
| Total Liquidity Resources | $ | 351,740 | $ | 345,440 | ||||
18 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2025 | December 31, 2024 | ||||||
| Non-Bank legal entities | ||||||||
| U.S.: | ||||||||
Parent Company | $ | 79,172 | $ | 71,981 | ||||
Non-Parent Company | 58,994 | 61,684 | ||||||
| Total U.S. | 138,166 | 133,665 | ||||||
| Non-U.S. | 63,092 | 61,432 | ||||||
| Total Non-Bank legal entities | 201,258 | 195,097 | ||||||
| Bank legal entities | ||||||||
| U.S. | 144,302 | 144,735 | ||||||
| Non-U.S. | 6,180 | 5,608 | ||||||
| Total Bank legal entities | 150,482 | 150,343 | ||||||
| Total Liquidity Resources | $ | 351,740 | $ | 345,440 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2025 | December 31, 2024 | ||||||
Eligible HQLA | ||||||||
| Cash deposits with central banks | $ | 53,674 | $ | 53,836 | ||||
Securities1 | 221,883 | 213,394 | ||||||
Total Eligible HQLA | $ | 275,557 | $ | 267,230 | ||||
Net cash outflows | $ | 212,276 | $ | 205,780 | ||||
| LCR | 130 | % | 130 | % | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 259,274 | $ | 242,424 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 85,876 | $ | 65,293 | ||||
Securities received as collateral1 | $ | 3,159 | $ | 9,625 | ||||
| March 2025 Form 10-Q | 19 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2025 | December 31, 2024 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 237,750 | $ | 250,354 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 84,782 | $ | 74,949 | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Savings and demand deposits: | ||||||||
Brokerage sweep deposits1 | $ | 138,013 | $ | 142,550 | ||||
| Savings and other | 163,877 | 157,348 | ||||||
| Total Savings and demand deposits | 301,890 | 299,898 | ||||||
Time deposits2 | 79,673 | 76,109 | ||||||
Total3 | $ | 381,563 | $ | 376,007 | ||||
| $ in millions | Parent Company | Subsidiaries | Total | ||||||||
| Original maturities of one year or less | $ | — | $ | 8,393 | $ | 8,393 | |||||
| Original maturities greater than one year | |||||||||||
| 2025 | $ | 5,874 | $ | 10,644 | $ | 16,518 | |||||
| 2026 | 22,605 | 13,799 | 36,404 | ||||||||
| 2027 | 21,175 | 13,500 | 34,675 | ||||||||
| 2028 | 14,025 | 16,682 | 30,707 | ||||||||
| 2029 | 16,636 | 13,466 | 30,102 | ||||||||
| Thereafter | 106,898 | 41,693 | 148,591 | ||||||||
| Total greater than one year | $ | 187,213 | $ | 109,784 | $ | 296,997 | |||||
| Total | $ | 187,213 | $ | 118,177 | $ | 305,390 | |||||
Maturities over next 12 months2 | $ | 22,963 | |||||||||
20 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Parent Company | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| DBRS, Inc. | R-1 (middle) | A (high) | Positive | ||||||||
| Fitch Ratings, Inc. | F1 | A+ | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | A1 | Stable | ||||||||
| Rating and Investment Information, Inc. | a-1 | A+ | Stable | ||||||||
| S&P Global Ratings | A-2 | A- | Stable | ||||||||
| MSBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| MSPBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| Three Months Ended March 31, | ||||||||
| in millions, except for per share data | 2025 | 2024 | ||||||
| Number of shares | 8 | 12 | ||||||
| Average price per share | $ | 125.88 | $ | 86.79 | ||||
| Total | $ | 1,000 | $ | 1,000 | ||||
| Announcement date | April 11, 2025 | ||||
| Amount per share | $0.925 | ||||
| Date to be paid | May 15, 2025 | ||||
| Shareholders of record as of | April 30, 2025 | ||||
| March 2025 Form 10-Q | 21 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
At March 31, 2025 and December 31, 2024 | ||||||||
| Standardized | Advanced | |||||||
| Capital buffers | ||||||||
| Capital conservation buffer | — | 2.5% | ||||||
SCB1 | 6.0% | N/A | ||||||
G-SIB capital surcharge2 | 3.0% | 3.0% | ||||||
CCyB3 | 0% | 0% | ||||||
| Capital buffer requirement | 9.0% | 5.5% | ||||||
| Regulatory Minimum | At March 31, 2025 and December 31, 2024 | ||||||||||
| Standardized | Advanced | ||||||||||
Required ratios1 | |||||||||||
CET1 capital ratio | 4.5 | % | 13.5% | 10.0% | |||||||
| Tier 1 capital ratio | 6.0 | % | 15.0% | 11.5% | |||||||
| Total capital ratio | 8.0 | % | 17.0% | 13.5% | |||||||
22 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Standardized | Advanced | ||||||||||||||||
| $ in millions | At March 31, 2025 | At Dec 31, 2024 | At March 31, 2025 | At Dec 31, 2024 | |||||||||||||
Risk-based capital | |||||||||||||||||
| CET1 capital | $ | 76,975 | $ | 75,095 | $ | 76,975 | $ | 75,095 | |||||||||
| Tier 1 capital | 86,674 | 84,790 | 86,674 | 84,790 | |||||||||||||
| Total capital | 97,772 | 95,567 | 97,020 | 94,846 | |||||||||||||
| Total RWA | 502,622 | 471,834 | 489,316 | 477,331 | |||||||||||||
Risk-based capital ratios | |||||||||||||||||
| CET1 capital | 15.3 | % | 15.9 | % | 15.7 | % | 15.7 | % | |||||||||
| Tier 1 capital | 17.2 | % | 18.0 | % | 17.7 | % | 17.8 | % | |||||||||
| Total capital | 19.5 | % | 20.3 | % | 19.8 | % | 19.9 | % | |||||||||
Required ratios1 | |||||||||||||||||
| CET1 capital | 13.5 | % | 13.5 | % | 10.0 | % | 10.0 | % | |||||||||
| Tier 1 capital | 15.0 | % | 15.0 | % | 11.5 | % | 11.5 | % | |||||||||
| Total capital | 17.0 | % | 17.0 | % | 13.5 | % | 13.5 | % | |||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Leveraged-based capital | ||||||||
Adjusted average assets1 | $ | 1,251,047 | $ | 1,223,779 | ||||
Supplementary leverage exposure2 | 1,552,615 | 1,517,687 | ||||||
Leveraged-based capital ratios | ||||||||
| Tier 1 leverage | 6.9 | % | 6.9 | % | ||||
| SLR | 5.6 | % | 5.6 | % | ||||
Required ratios3 | ||||||||
| Tier 1 leverage | 4.0 | % | 4.0 | % | ||||
| SLR | 5.0 | % | 5.0 | % | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | Change | ||||||||
CET1 capital | |||||||||||
Common shareholders' equity | $ | 97,062 | $ | 94,761 | $ | 2,301 | |||||
Regulatory adjustments and deductions: | |||||||||||
| Net goodwill | (16,371) | (16,354) | (17) | ||||||||
| Net intangible assets | (4,888) | (5,003) | 115 | ||||||||
Impact of CECL transition | — | 62 | (62) | ||||||||
Other adjustments and deductions1 | 1,172 | 1,629 | (457) | ||||||||
Total CET1 capital | $ | 76,975 | $ | 75,095 | $ | 1,880 | |||||
| Additional Tier 1 capital | |||||||||||
| Preferred stock | $ | 9,750 | $ | 9,750 | $ | — | |||||
| Noncontrolling interests | 881 | 807 | 74 | ||||||||
| Additional Tier 1 capital | $ | 10,631 | $ | 10,557 | $ | 74 | |||||
| Deduction for investments in covered funds | (932) | (862) | (70) | ||||||||
| Total Tier 1 capital | $ | 86,674 | $ | 84,790 | $ | 1,884 | |||||
| Standardized Tier 2 capital | |||||||||||
| Subordinated debt | $ | 9,051 | $ | 8,851 | $ | 200 | |||||
| Eligible ACL | 2,299 | 2,065 | 234 | ||||||||
| Other adjustments and deductions | (252) | (139) | (113) | ||||||||
| Total Standardized Tier 2 capital | $ | 11,098 | $ | 10,777 | $ | 321 | |||||
| Total Standardized capital | $ | 97,772 | $ | 95,567 | $ | 2,205 | |||||
| Advanced Tier 2 capital | |||||||||||
| Subordinated debt | $ | 9,051 | $ | 8,851 | $ | 200 | |||||
| Eligible credit reserves | 1,547 | 1,344 | 203 | ||||||||
| Other adjustments and deductions | (252) | (139) | (113) | ||||||||
| Total Advanced Tier 2 capital | $ | 10,346 | $ | 10,056 | $ | 290 | |||||
| Total Advanced capital | $ | 97,020 | $ | 94,846 | $ | 2,174 | |||||
| March 2025 Form 10-Q | 23 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, 2025 | ||||||||
| $ in millions | Standardized | Advanced | ||||||
| Credit risk RWA | ||||||||
| Balance at December 31, 2024 | $ | 417,982 | $ | 316,429 | ||||
| Change related to the following items: | ||||||||
| Derivatives | 8,764 | 5,652 | ||||||
| Securities financing transactions | 9,844 | 1,763 | ||||||
| Investment securities | (949) | 49 | ||||||
| Commitments, guarantees and loans | 1,513 | (4,314) | ||||||
| Equity investments | 302 | 306 | ||||||
| Other credit risk | 6,167 | 5,143 | ||||||
| Total change in credit risk RWA | $ | 25,641 | $ | 8,599 | ||||
| Balance at March 31, 2025 | $ | 443,623 | $ | 325,028 | ||||
| Market risk RWA | ||||||||
| Balance at December 31, 2024 | $ | 53,852 | $ | 54,322 | ||||
| Change related to the following items: | ||||||||
| Regulatory VaR | 1,037 | 1,037 | ||||||
| Regulatory stressed VaR | 1,370 | 1,370 | ||||||
| Incremental risk charge | (1,983) | (1,983) | ||||||
| Comprehensive risk measure | (233) | (437) | ||||||
| Specific risk | 4,956 | 4,956 | ||||||
| Total change in market risk RWA | $ | 5,147 | $ | 4,943 | ||||
| Balance at March 31, 2025 | $ | 58,999 | $ | 59,265 | ||||
| Operational risk RWA | ||||||||
| Balance at December 31, 2024 | N/A | $ | 106,580 | |||||
| Change in operational risk RWA | N/A | (1,557) | ||||||
| Balance at March 31, 2025 | N/A | $ | 105,023 | |||||
| Total RWA | $ | 502,622 | $ | 489,316 | ||||
| Actual Amount/Ratio | ||||||||||||||
| $ in millions | Regulatory Minimum | Required Ratio1 | At March 31, 2025 | At December 31, 2024 | ||||||||||
External TLAC2 | $ | 268,879 | $ | 266,146 | ||||||||||
| External TLAC as a % of RWA | 18.0 | % | 21.5 | % | 53.5 | % | 55.8 | % | ||||||
| External TLAC as a % of leverage exposure | 7.5 | % | 9.5 | % | 17.3 | % | 17.5 | % | ||||||
Eligible LTD3 | $ | 169,619 | $ | 169,690 | ||||||||||
| Eligible LTD as a % of RWA | 9.0 | % | 9.0 | % | 33.7 | % | 35.5 | % | ||||||
| Eligible LTD as a % of leverage exposure | 4.5 | % | 4.5 | % | 10.9 | % | 11.2 | % | ||||||
24 | March 2025 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2025 | 2024 | ||||||
| Institutional Securities | $ | 48.4 | $ | 45.0 | ||||
| Wealth Management | 29.4 | 29.1 | ||||||
| Investment Management | 10.6 | 10.8 | ||||||
Parent Company | 7.1 | 5.0 | ||||||
| Total | $ | 95.5 | $ | 89.9 | ||||
| March 2025 Form 10-Q | 25 | |||||||
| Three Months Ended | ||||||||||||||
| March 31, 2025 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 25 | $ | 30 | $ | 39 | $ | 22 | ||||||
| Equity price | 23 | 23 | 26 | 19 | ||||||||||
| Foreign exchange rate | 9 | 11 | 15 | 7 | ||||||||||
| Commodity price | 22 | 17 | 27 | 12 | ||||||||||
Less: Diversification benefit2 | (40) | (35) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 39 | $ | 46 | $ | 54 | $ | 39 | ||||||
| Credit Portfolio | 18 | 19 | 23 | 18 | ||||||||||
Less: Diversification benefit2 | (11) | (15) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 46 | $ | 50 | $ | 60 | $ | 43 | ||||||
| Three Months Ended | ||||||||||||||
| December 31, 2024 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 23 | $ | 28 | $ | 43 | $ | 19 | ||||||
| Equity price | 21 | 24 | 39 | 18 | ||||||||||
| Foreign exchange rate | 10 | 9 | 13 | 6 | ||||||||||
| Commodity price | 18 | 15 | 20 | 11 | ||||||||||
Less: Diversification benefit2 | (37) | (36) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 35 | $ | 40 | $ | 59 | $ | 32 | ||||||
| Credit Portfolio | 20 | 21 | 23 | 20 | ||||||||||
Less: Diversification benefit2 | (16) | (15) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 39 | $ | 46 | $ | 64 | $ | 39 | ||||||
26 | March 2025 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||


| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Derivatives | $ | 6 | $ | 6 | ||||
| Borrowings carried at fair value | 52 | 49 | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Basis point change | ||||||||
+200 | $ | 563 | $ | 699 | ||||
| +100 | 285 | 350 | ||||||
| -100 | (313) | (371) | ||||||
-200 | (697) | (803) | ||||||
| March 2025 Form 10-Q | 27 | |||||||
| Risk Disclosures | ![]() | ||||
| Loss from 10% Decline | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Investments related to Investment Management activities | $ | 537 | $ | 571 | ||||
| Other investments: | ||||||||
| MUMSS | 132 | 122 | ||||||
| Other Firm investments | 475 | 463 | ||||||
| At March 31, 2025 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 7,733 | $ | 11,994 | $ | — | $ | 19,727 | ||||||
| Secured lending facilities | 51,329 | 3,680 | — | 55,009 | ||||||||||
| Commercial and Residential real estate | 8,610 | 290 | 3,344 | 12,244 | ||||||||||
| Securities-based lending and Other | 3,372 | 147 | 6,471 | 9,990 | ||||||||||
| Total Institutional Securities | 71,044 | 16,111 | 9,815 | 96,970 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 67,579 | — | — | 67,579 | ||||||||||
| Securities-based lending and Other | 95,298 | — | — | 95,298 | ||||||||||
| Total Wealth Management | 162,877 | — | — | 162,877 | ||||||||||
Total Investment Management2 | 4 | — | 251 | 255 | ||||||||||
| Total loans | 233,925 | 16,111 | 10,066 | 260,102 | ||||||||||
| ACL | (1,133) | (1,133) | ||||||||||||
| Total loans, net of ACL | $ | 232,792 | $ | 16,111 | $ | 10,066 | $ | 258,969 | ||||||
Lending commitments3 | $ | 151,574 | $ | 27,924 | $ | 562 | $ | 180,060 | ||||||
| Total exposure | $ | 384,366 | $ | 44,035 | $ | 10,628 | $ | 439,029 | ||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 6,889 | $ | 9,183 | $ | — | $ | 16,072 | ||||||
| Secured lending facilities | 48,842 | 2,507 | — | 51,349 | ||||||||||
| Commercial and Residential real estate | 8,412 | 628 | 2,420 | 11,460 | ||||||||||
| Securities-based lending and Other | 2,876 | — | 6,041 | 8,917 | ||||||||||
| Total Institutional Securities | 67,019 | 12,318 | 8,461 | 87,798 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 66,738 | — | — | 66,738 | ||||||||||
| Securities-based lending and Other | 93,139 | 1 | — | 93,140 | ||||||||||
| Total Wealth Management | 159,877 | 1 | — | 159,878 | ||||||||||
Total Investment Management2 | 4 | — | 200 | 204 | ||||||||||
| Total loans | 226,900 | 12,319 | 8,661 | 247,880 | ||||||||||
| ACL | (1,066) | (1,066) | ||||||||||||
| Total loans, net of ACL | $ | 225,834 | $ | 12,319 | $ | 8,661 | $ | 246,814 | ||||||
Lending commitments3 | $ | 148,818 | $ | 26,955 | $ | 758 | $ | 176,531 | ||||||
| Total exposure | $ | 374,652 | $ | 39,274 | $ | 9,419 | $ | 423,345 | ||||||
28 | March 2025 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| $ in millions | Three Months Ended March 31, 2025 | ||||
| ACL—Loans | |||||
| Beginning balance | $ | 1,066 | |||
| Gross charge-offs | (31) | ||||
| Recoveries | 8 | ||||
Net (charge-offs)/recoveries | (23) | ||||
| Provision for credit losses | 81 | ||||
| Other | 9 | ||||
Ending balance | $ | 1,133 | |||
ACL—Lending commitments | |||||
| Beginning balance | $ | 656 | |||
| Provision for credit losses | 54 | ||||
| Other | 8 | ||||
Ending balance | $ | 718 | |||
Total ending balance | $ | 1,851 | |||
| Three Months Ended March 31, 2025 | |||||||||||
| $ in millions | IS | WM | Total | ||||||||
| Loans | $ | 37 | $ | 44 | $ | 81 | |||||
| Lending commitments | 54 | — | 54 | ||||||||
| Total | $ | 91 | $ | 44 | $ | 135 | |||||
| 4Q 2025 | 4Q 2026 | |||||||
| Year-over-year growth rate | 1.5 | % | 1.9 | % | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| IS | WM | IS | WM | |||||||||||
| Accrual | 99.1 | % | 99.7 | % | 99.2 | % | 99.7 | % | ||||||
Nonaccrual1 | 0.9 | % | 0.3 | % | 0.8 | % | 0.3 | % | ||||||
| March 2025 Form 10-Q | 29 | |||||||
| Risk Disclosures | ![]() | ||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
For the Three Months Ended March 31, 2025 | ||||||||||||||||||||
Net charge-off/(recovery) ratio1 | — | % | — | % | 0.27 | % | — | % | — | % | 0.01 | % | ||||||||
| Average loans | $ | 7,210 | $ | 50,310 | $ | 8,493 | $ | 51,572 | $ | 97,249 | $ | 214,834 | ||||||||
| At March 31, 2025 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 1,452 | $ | — | $ | 8 | $ | — | $ | 1,460 | |||||||
| A | 883 | 763 | 164 | — | 1,810 | ||||||||||||
| BBB | 5,282 | 14,272 | 111 | 157 | 19,822 | ||||||||||||
| BB | 10,144 | 29,329 | 2,466 | 498 | 42,437 | ||||||||||||
| Other NIG | 7,954 | 11,369 | 5,508 | 149 | 24,980 | ||||||||||||
Unrated2 | 324 | 1,334 | 1,117 | 2,933 | 5,708 | ||||||||||||
| Total loans, net of ACL | 26,039 | 57,067 | 9,374 | 3,737 | 96,217 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 75 | — | — | 75 | ||||||||||||
| AA | 2,345 | 3,051 | 855 | — | 6,251 | ||||||||||||
| A | 5,233 | 21,385 | 2,036 | — | 28,654 | ||||||||||||
| BBB | 10,100 | 57,465 | 948 | 158 | 68,671 | ||||||||||||
| BB | 1,754 | 25,493 | 7,026 | 902 | 35,175 | ||||||||||||
| Other NIG | 1,828 | 17,699 | 2,223 | 2 | 21,752 | ||||||||||||
Unrated2 | 81 | 27 | 4 | — | 112 | ||||||||||||
| Total lending commitments | 21,341 | 125,195 | 13,092 | 1,062 | 160,690 | ||||||||||||
| Total exposure | $ | 47,380 | $ | 182,262 | $ | 22,466 | $ | 4,799 | $ | 256,907 | |||||||
| At December 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 3 | $ | 575 | $ | 187 | $ | — | $ | 765 | |||||||
| A | 894 | 588 | 164 | — | 1,646 | ||||||||||||
| BBB | 5,165 | 13,185 | 91 | 124 | 18,565 | ||||||||||||
| BB | 11,235 | 24,467 | 2,592 | 358 | 38,652 | ||||||||||||
| Other NIG | 8,520 | 12,776 | 1,673 | 145 | 23,114 | ||||||||||||
Unrated2 | 227 | 1,176 | 420 | 2,503 | 4,326 | ||||||||||||
| Total loans, net of ACL | 26,044 | 52,767 | 5,127 | 3,130 | 87,068 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 75 | — | — | 75 | ||||||||||||
| AA | 2,560 | 4,285 | 88 | — | 6,933 | ||||||||||||
| A | 8,226 | 21,372 | 1,091 | — | 30,689 | ||||||||||||
| BBB | 10,135 | 54,752 | 1,507 | 146 | 66,540 | ||||||||||||
| BB | 3,174 | 23,239 | 3,062 | 941 | 30,416 | ||||||||||||
| Other NIG | 1,074 | 17,436 | 3,956 | 2 | 22,468 | ||||||||||||
Unrated2 | 14 | 93 | 33 | — | 140 | ||||||||||||
| Total lending commitments | 25,183 | 121,252 | 9,737 | 1,089 | 157,261 | ||||||||||||
| Total exposure | $ | 51,227 | $ | 174,019 | $ | 14,864 | $ | 4,219 | $ | 244,329 | |||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Industry | ||||||||
| Financials | $ | 76,168 | $ | 68,512 | ||||
| Real estate | 41,535 | 40,041 | ||||||
| Industrials | 22,748 | 20,024 | ||||||
| Information technology | 18,652 | 15,666 | ||||||
| Communications services | 18,532 | 20,425 | ||||||
| Consumer discretionary | 15,406 | 14,699 | ||||||
| Healthcare | 14,827 | 15,455 | ||||||
| Utilities | 12,071 | 11,755 | ||||||
| Consumer staples | 10,617 | 12,098 | ||||||
| Energy | 8,593 | 9,036 | ||||||
| Materials | 7,144 | 7,378 | ||||||
| Insurance | 6,848 | 6,812 | ||||||
| Other | 3,766 | 2,428 | ||||||
| Total exposure | $ | 256,907 | $ | 244,329 | ||||
30 | March 2025 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| At March 31, 2025 | ||||||||||||||
| Contractual Years to Maturity | ||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | Total | ||||||||||
| Loans, net of ACL | $ | 2,782 | $ | 1,165 | $ | 4,743 | $ | 8,690 | ||||||
| Lending commitments | 3,464 | 2,865 | 3,208 | 9,537 | ||||||||||
| Total exposure | $ | 6,246 | $ | 4,030 | $ | 7,951 | $ | 18,227 | ||||||
| At December 31, 2024 | ||||||||||||||
| Contractual Years to Maturity | ||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | Total | ||||||||||
| Loans, net of ACL | $ | 2,253 | $ | 2,839 | $ | 733 | $ | 5,825 | ||||||
| Lending commitments | 5,153 | 2,152 | 2,918 | 10,223 | ||||||||||
| Total exposure | $ | 7,406 | $ | 4,991 | $ | 3,651 | $ | 16,048 | ||||||
| At March 31, 2025 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 7,733 | $ | 107,667 | $ | 115,400 | |||||
| Secured lending facilities | 51,329 | 23,001 | 74,330 | ||||||||
| Commercial real estate | 8,610 | 303 | 8,913 | ||||||||
| Securities-based lending and Other | 3,372 | 1,233 | 4,605 | ||||||||
| Total, before ACL | $ | 71,044 | $ | 132,204 | $ | 203,248 | |||||
| ACL | $ | (753) | $ | (702) | $ | (1,455) | |||||
| At December 31, 2024 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 6,889 | $ | 105,824 | $ | 112,713 | |||||
| Secured lending facilities | 48,842 | 20,971 | 69,813 | ||||||||
| Commercial real estate | 8,412 | 1,249 | 9,661 | ||||||||
| Securities-based lending and Other | 2,876 | 1,504 | 4,380 | ||||||||
| Total, before ACL | $ | 67,019 | $ | 129,548 | $ | 196,567 | |||||
| ACL | $ | (730) | $ | (640) | $ | (1,370) | |||||
| At March 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total Exposure | Loans1 | LC1 | Total Exposure | |||||||||||||||||
| Americas | $ | 5,238 | $ | 177 | $ | 5,415 | $ | 5,066 | $ | 820 | $ | 5,886 | |||||||||||
| EMEA | 3,861 | 204 | 4,065 | 3,806 | 522 | 4,328 | |||||||||||||||||
| Asia | 420 | 17 | 437 | 467 | 13 | 480 | |||||||||||||||||
Total | $ | 9,519 | $ | 398 | $ | 9,917 | $ | 9,339 | $ | 1,355 | $ | 10,694 | |||||||||||
| At March 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total Exposure | Loans1 | LC1 | Total Exposure | |||||||||||||||||
| Office | $ | 2,941 | $ | 108 | $ | 3,049 | $ | 2,846 | $ | 109 | $ | 2,955 | |||||||||||
| Industrial | 2,709 | 145 | 2,854 | 2,610 | 125 | 2,735 | |||||||||||||||||
| Multifamily | 1,988 | 76 | 2,064 | 2,042 | 80 | 2,122 | |||||||||||||||||
| Retail | 1,007 | 13 | 1,020 | 1,105 | 971 | 2,076 | |||||||||||||||||
| Hotel | 874 | 56 | 930 | 736 | 70 | 806 | |||||||||||||||||
| Total | $ | 9,519 | $ | 398 | $ | 9,917 | $ | 9,339 | $ | 1,355 | $ | 10,694 | |||||||||||
| March 2025 Form 10-Q | 31 | |||||||
| Risk Disclosures | ![]() | ||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | SBL and Other | Total | ||||||||||||
| ACL—Loans | |||||||||||||||||
Beginning balance | $ | 200 | $ | 140 | $ | 373 | $ | 17 | $ | 730 | |||||||
| Gross charge-offs | — | — | (31) | — | (31) | ||||||||||||
| Recoveries | — | — | 8 | — | 8 | ||||||||||||
Net (charge-offs)/ recoveries | — | — | (23) | — | (23) | ||||||||||||
Provision (release) | 2 | 7 | 24 | 4 | 37 | ||||||||||||
| Other | 3 | 2 | 5 | (1) | 9 | ||||||||||||
Ending balance | $ | 205 | $ | 149 | $ | 379 | $ | 20 | $ | 753 | |||||||
ACL—Lending commitments | |||||||||||||||||
Beginning balance | $ | 507 | $ | 88 | $ | 40 | $ | 5 | $ | 640 | |||||||
Provision (release) | 37 | 41 | (27) | 3 | 54 | ||||||||||||
| Other | 5 | 1 | — | 2 | 8 | ||||||||||||
Ending balance | $ | 549 | $ | 130 | $ | 13 | $ | 10 | $ | 702 | |||||||
Total ending balance | $ | 754 | $ | 279 | $ | 392 | $ | 30 | $ | 1,455 | |||||||
| At March 31, 2025 | At December 31, 2024 | |||||||
| Corporate | 2.7 | % | 2.9 | % | ||||
| Secured lending facilities | 0.3 | % | 0.3 | % | ||||
| Commercial real estate | 4.4 | % | 4.4 | % | ||||
| Securities-based lending and Other | 0.6 | % | 0.6 | % | ||||
| Total Institutional Securities loans | 1.1 | % | 1.1 | % | ||||
| At March 31, 2025 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 83,582 | $ | 10,326 | $ | 986 | $ | 144 | $ | 95,038 | |||||||
Residential real estate | 1 | 111 | 1,084 | 66,263 | 67,459 | ||||||||||||
| Total loans, net of ACL | $ | 83,583 | $ | 10,437 | $ | 2,070 | $ | 66,407 | $ | 162,497 | |||||||
| Lending commitments | 16,061 | 2,861 | 49 | 399 | 19,370 | ||||||||||||
| Total exposure | $ | 99,644 | $ | 13,298 | $ | 2,119 | $ | 66,806 | $ | 181,867 | |||||||
| At December 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 82,788 | $ | 8,944 | $ | 1,024 | $ | 145 | $ | 92,901 | |||||||
Residential real estate | 1 | 111 | 1,106 | 65,423 | 66,641 | ||||||||||||
| Total loans, net of ACL | $ | 82,789 | $ | 9,055 | $ | 2,130 | $ | 65,568 | $ | 159,542 | |||||||
| Lending commitments | 16,318 | 2,523 | 43 | 386 | 19,270 | ||||||||||||
| Total exposure | $ | 99,107 | $ | 11,578 | $ | 2,173 | $ | 65,954 | $ | 178,812 | |||||||
| At March 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total exposure | Loans1 | LC1 | Total exposure | |||||||||||||||||
| Retail | $ | 2,304 | $ | — | $ | 2,304 | $ | 2,293 | $ | — | $ | 2,293 | |||||||||||
| Multifamily | 1,931 | 231 | 2,162 | 1,928 | 261 | 2,189 | |||||||||||||||||
| Office | 2,013 | 1 | 2,014 | 1,951 | 11 | 1,962 | |||||||||||||||||
| Industrial | 466 | — | 466 | 456 | — | 456 | |||||||||||||||||
| Hotel | 442 | — | 442 | 442 | — | 442 | |||||||||||||||||
| Other | 394 | — | 394 | 309 | — | 309 | |||||||||||||||||
Total | $ | 7,550 | $ | 232 | $ | 7,782 | $ | 7,379 | $ | 272 | $ | 7,651 | |||||||||||
| Three Months Ended March 31, 2025 | |||||||||||
| $ in millions | Residential Real Estate | SBL and Other | Total | ||||||||
| ACL—Loans | |||||||||||
| Beginning balance | $ | 97 | $ | 239 | $ | 336 | |||||
| Provision (release) | 23 | 21 | 44 | ||||||||
Ending balance | $ | 120 | $ | 260 | $ | 380 | |||||
| ACL—Lending commitments | |||||||||||
| Beginning balance | $ | 4 | $ | 12 | $ | 16 | |||||
Ending balance | $ | 4 | $ | 12 | $ | 16 | |||||
Total ending balance | $ | 124 | $ | 272 | $ | 396 | |||||
32 | March 2025 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Institutional Securities | $ | 28,564 | $ | 27,612 | ||||
| Wealth Management | 28,284 | 28,270 | ||||||
| Total | $ | 56,848 | $ | 55,882 | ||||
| At March 31, 2025 | ||||||||||||||||||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| Less than 1 year | $ | 1,319 | $ | 13,363 | $ | 33,083 | $ | 17,284 | $ | 9,978 | $ | 75,027 | ||||||||
| 1-3 years | 354 | 5,091 | 15,176 | 9,060 | 6,256 | 35,937 | ||||||||||||||
| 3-5 years | 963 | 6,676 | 9,215 | 5,777 | 3,755 | 26,386 | ||||||||||||||
| Over 5 years | 3,254 | 24,739 | 48,670 | 26,922 | 6,604 | 110,189 | ||||||||||||||
| Total, gross | $ | 5,890 | $ | 49,869 | $ | 106,144 | $ | 59,043 | $ | 26,593 | $ | 247,539 | ||||||||
| Counterparty netting | (2,976) | (38,471) | (77,888) | (41,466) | (14,907) | (175,708) | ||||||||||||||
| Cash and securities collateral | (2,335) | (9,703) | (24,219) | (12,667) | (5,592) | (54,516) | ||||||||||||||
| Total, net | $ | 579 | $ | 1,695 | $ | 4,037 | $ | 4,910 | $ | 6,094 | $ | 17,315 | ||||||||
| At December 31, 2024 | ||||||||||||||||||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| Less than 1 year | $ | 1,711 | $ | 17,625 | $ | 50,643 | $ | 22,643 | $ | 9,793 | $ | 102,415 | ||||||||
| 1-3 years | 541 | 6,249 | 19,068 | 10,248 | 6,095 | 42,201 | ||||||||||||||
| 3-5 years | 973 | 7,308 | 9,821 | 5,631 | 3,750 | 27,483 | ||||||||||||||
| Over 5 years | 3,330 | 25,406 | 49,469 | 28,206 | 6,398 | 112,809 | ||||||||||||||
| Total, gross | $ | 6,555 | $ | 56,588 | $ | 129,001 | $ | 66,728 | $ | 26,036 | $ | 284,908 | ||||||||
| Counterparty netting | (3,320) | (44,604) | (98,598) | (47,132) | (14,691) | (208,345) | ||||||||||||||
| Cash and securities collateral | (2,559) | (10,632) | (25,568) | (13,729) | (5,558) | (58,046) | ||||||||||||||
| Total, net | $ | 676 | $ | 1,352 | $ | 4,835 | $ | 5,867 | $ | 5,787 | $ | 18,517 | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Industry | ||||||||
| Financials | $ | 5,437 | $ | 5,678 | ||||
| Utilities | 3,719 | 3,733 | ||||||
| Industrials | 1,004 | 1,315 | ||||||
| Energy | 949 | 987 | ||||||
| Consumer discretionary | 912 | 1,046 | ||||||
| Communications services | 837 | 914 | ||||||
| Regional governments | 760 | 799 | ||||||
| Information technology | 590 | 634 | ||||||
| Consumer staples | 588 | 734 | ||||||
| Sovereign governments | 511 | 683 | ||||||
| Healthcare | 458 | 353 | ||||||
| Materials | 377 | 409 | ||||||
| Insurance | 153 | 207 | ||||||
| Real estate | 124 | 91 | ||||||
| Not-for-profit organizations | 124 | 94 | ||||||
| Other | 772 | 840 | ||||||
| Total | $ | 17,315 | $ | 18,517 | ||||
| March 2025 Form 10-Q | 33 | |||||||
| Risk Disclosures | ![]() | ||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | United Kingdom | France | Germany | Brazil | Japan | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | (289) | $ | 4,943 | $ | (1,796) | $ | 5,926 | $ | 2,393 | |||||||
Net counterparty exposure2 | 13 | 2 | 72 | — | 9 | ||||||||||||
| Exposure before hedges | (276) | 4,945 | (1,724) | 5,926 | 2,402 | ||||||||||||
Hedges3 | (55) | (162) | (242) | (134) | (173) | ||||||||||||
| Net exposure | $ | (331) | $ | 4,783 | $ | (1,966) | $ | 5,792 | $ | 2,229 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 2,355 | $ | 1,698 | $ | 1,407 | $ | 37 | $ | 756 | |||||||
Net counterparty exposure2 | 9,790 | 3,553 | 2,905 | 334 | 3,239 | ||||||||||||
| Loans | 8,384 | 575 | 2,557 | 162 | 668 | ||||||||||||
| Lending commitments | 9,451 | 3,198 | 5,717 | 404 | — | ||||||||||||
| Exposure before hedges | 29,980 | 9,024 | 12,586 | 937 | 4,663 | ||||||||||||
Hedges3 | (1,838) | (1,443) | (1,825) | (57) | (222) | ||||||||||||
| Net exposure | $ | 28,142 | $ | 7,581 | $ | 10,761 | $ | 880 | $ | 4,441 | |||||||
| Total net exposure | $ | 27,811 | $ | 12,364 | $ | 8,795 | $ | 6,672 | $ | 6,670 | |||||||
| $ in millions | Spain | Netherlands | Korea | India | Italy | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | 1,136 | $ | 509 | $ | 2,737 | $ | 2,176 | $ | 2,092 | |||||||
Net counterparty exposure2 | — | — | 338 | — | 12 | ||||||||||||
| Exposure before hedges | 1,136 | 509 | 3,075 | 2,176 | 2,104 | ||||||||||||
Hedges3 | (8) | (12) | (35) | — | (29) | ||||||||||||
| Net exposure | $ | 1,128 | $ | 497 | $ | 3,040 | $ | 2,176 | $ | 2,075 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 712 | $ | 759 | $ | 180 | $ | 953 | $ | 167 | |||||||
Net counterparty exposure2 | 427 | 674 | 963 | 749 | 843 | ||||||||||||
| Loans | 2,158 | 1,397 | — | 52 | 174 | ||||||||||||
| Lending commitments | 689 | 974 | — | — | 881 | ||||||||||||
| Exposure before hedges | 3,986 | 3,804 | 1,143 | 1,754 | 2,065 | ||||||||||||
Hedges3 | (277) | (130) | (35) | (10) | (335) | ||||||||||||
| Net exposure | $ | 3,709 | $ | 3,674 | $ | 1,108 | $ | 1,744 | $ | 1,730 | |||||||
| Total net exposure | $ | 4,837 | $ | 4,171 | $ | 4,148 | $ | 3,920 | $ | 3,805 | |||||||
34 | March 2025 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| March 2025 Form 10-Q | 35 | |||||||
/s/ Deloitte & Touche LLP | ||
| New York, New York | ||
| May 5, 2025 | ||
36 | March 2025 Form 10-Q | |||||||
| Consolidated Income Statement (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| in millions, except per share data | 2025 | 2024 | ||||||
| Revenues | ||||||||
| Investment banking | $ | $ | ||||||
| Trading | ||||||||
| Investments | ||||||||
| Commissions and fees | ||||||||
| Asset management | ||||||||
| Other | ||||||||
| Total non-interest revenues | ||||||||
Interest income | ||||||||
Interest expense | ||||||||
| Net interest | ||||||||
| Net revenues | ||||||||
| Provision for credit losses | ( | |||||||
| Non-interest expenses | ||||||||
| Compensation and benefits | ||||||||
| Brokerage, clearing and exchange fees | ||||||||
| Information processing and communications | ||||||||
| Professional services | ||||||||
| Occupancy and equipment | ||||||||
| Marketing and business development | ||||||||
| Other | ||||||||
| Total non-interest expenses | ||||||||
| Income before provision for income taxes | ||||||||
| Provision for income taxes | ||||||||
| Net income | $ | $ | ||||||
| Net income applicable to noncontrolling interests | ||||||||
| Net income applicable to Morgan Stanley | $ | $ | ||||||
| Preferred stock dividends | ||||||||
| Earnings applicable to Morgan Stanley common shareholders | $ | $ | ||||||
| Earnings per common share | ||||||||
| Basic | $ | $ | ||||||
| Diluted | $ | $ | ||||||
| Average common shares outstanding | ||||||||
| Basic | ||||||||
| Diluted | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Net income | $ | $ | ||||||
| Other comprehensive income (loss), net of tax: | ||||||||
| Foreign currency translation adjustments | ( | |||||||
| Change in net unrealized gains (losses) on available-for-sale securities | ||||||||
| Pension and other | ||||||||
| Change in net debt valuation adjustment | ( | |||||||
| Net change in cash flow hedges | ( | |||||||
| Total other comprehensive income (loss) | $ | $ | ( | |||||
| Comprehensive income | $ | $ | ||||||
| Net income applicable to noncontrolling interests | ||||||||
| Other comprehensive income (loss) applicable to noncontrolling interests | ( | |||||||
| Comprehensive income applicable to Morgan Stanley | $ | $ | ||||||
| See Notes to Consolidated Financial Statements | 37 | March 2025 Form 10-Q | ||||||
| Consolidated Balance Sheet | ![]() | ||||
| $ in millions, except share data | (Unaudited) At March 31, 2025 | At December 31, 2024 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
Trading assets at fair value ($ | ||||||||
| Investment securities: | ||||||||
Available-for-sale at fair value (amortized cost of $ | ||||||||
Held-to-maturity (fair value of $ | ||||||||
Securities purchased under agreements to resell (includes $ | ||||||||
| Securities borrowed | ||||||||
| Customer and other receivables | ||||||||
| Loans: | ||||||||
Held for investment (net of allowance for credit losses of $ | ||||||||
| Held for sale | ||||||||
| Goodwill | ||||||||
Intangible assets (net of accumulated amortization of $ | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities | ||||||||
Deposits (includes $ | $ | $ | ||||||
| Trading liabilities at fair value | ||||||||
Securities sold under agreements to repurchase (includes $ | ||||||||
| Securities loaned | ||||||||
Other secured financings (includes $ | ||||||||
| Customer and other payables | ||||||||
| Other liabilities and accrued expenses | ||||||||
Borrowings (includes $ | ||||||||
| Total liabilities | ||||||||
| Commitments and contingent liabilities (see Note 13) | ||||||||
| Morgan Stanley shareholders’ equity: | ||||||||
| Preferred stock | ||||||||
Common stock, $ | ||||||||
Shares authorized: | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Employee stock trusts | ||||||||
| Accumulated other comprehensive income (loss) | ( | ( | ||||||
Common stock held in treasury at cost, $ | ( | ( | ||||||
| Common stock issued to employee stock trusts | ( | ( | ||||||
| Total Morgan Stanley shareholders’ equity | ||||||||
| Noncontrolling interests | ||||||||
| Total equity | ||||||||
| Total liabilities and equity | $ | $ | ||||||
| March 2025 Form 10-Q | 38 | See Notes to Consolidated Financial Statements | ||||||
Consolidated Statement of Changes in Total Equity (Unaudited) | ![]() | |||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
Preferred stock | ||||||||
Beginning and ending balance | $ | $ | ||||||
Common stock | ||||||||
| Beginning and ending balance | ||||||||
Additional paid-in capital | ||||||||
| Beginning balance | ||||||||
| Share-based award activity | ( | ( | ||||||
| Ending balance | ||||||||
Retained earnings | ||||||||
| Beginning balance | ||||||||
Cumulative adjustment related to the adoption of an accounting standard update1 | ( | |||||||
| Net income applicable to Morgan Stanley | ||||||||
Preferred stock dividends2 | ( | ( | ||||||
Common stock dividends2 | ( | ( | ||||||
| Other net increases (decreases) | ( | ( | ||||||
| Ending balance | ||||||||
Employee stock trusts | ||||||||
| Beginning balance | ||||||||
| Share-based award activity | ( | |||||||
| Ending balance | ||||||||
Accumulated other comprehensive income (loss) | ||||||||
| Beginning balance | ( | ( | ||||||
| Net change in Accumulated other comprehensive income (loss) | ( | |||||||
| Ending balance | ( | ( | ||||||
Common stock held in treasury at cost | ||||||||
| Beginning balance | ( | ( | ||||||
| Share-based award activity | ||||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ||||||
| Ending balance | ( | ( | ||||||
Common stock issued to employee stock trusts | ||||||||
| Beginning balance | ( | ( | ||||||
| Share-based award activity | ( | |||||||
| Ending balance | ( | ( | ||||||
Noncontrolling interests | ||||||||
| Beginning balance | ||||||||
| Net income applicable to noncontrolling interests | ||||||||
| Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests | ( | |||||||
| Other net increases (decreases) | ||||||||
| Ending balance | ||||||||
Total equity | $ | $ | ||||||
| See Notes to Consolidated Financial Statements | 39 | March 2025 Form 10-Q | ||||||
| Consolidated Cash Flow Statement (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | $ | ||||||
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||||||
| Stock-based compensation expense | ||||||||
| Depreciation and amortization | ||||||||
| Provision for credit losses | ( | |||||||
| Other operating adjustments | ( | ( | ||||||
| Changes in assets and liabilities: | ||||||||
| Trading assets, net of Trading liabilities | ( | ( | ||||||
| Securities borrowed | ( | ( | ||||||
| Securities loaned | ||||||||
| Customer and other receivables and other assets | ( | |||||||
| Customer and other payables and other liabilities | ||||||||
| Securities purchased under agreements to resell | ( | ( | ||||||
| Securities sold under agreements to repurchase | ||||||||
| Net cash provided by (used for) operating activities | ( | |||||||
| Cash flows from investing activities | ||||||||
| Proceeds from (payments for): | ||||||||
| Other assets—Premises, equipment and software | ( | ( | ||||||
| Changes in loans, net | ( | ( | ||||||
| AFS securities: | ||||||||
| Purchases | ( | ( | ||||||
| Proceeds from sales | ||||||||
| Proceeds from paydowns and maturities | ||||||||
| HTM securities: | ||||||||
| Purchases | ( | |||||||
| Proceeds from paydowns and maturities | ||||||||
| Other investing activities | ( | ( | ||||||
| Net cash provided by (used for) investing activities | ( | |||||||
| Cash flows from financing activities | ||||||||
| Net proceeds from (payments for): | ||||||||
| Other secured financings | ( | |||||||
| Deposits | ||||||||
| Proceeds from issuance of Borrowings | ||||||||
| Payments for: | ||||||||
| Borrowings | ( | ( | ||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ||||||
| Cash dividends | ( | ( | ||||||
| Other financing activities | ( | |||||||
| Net cash provided by (used for) financing activities | ||||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | |||||||
| Net increase (decrease) in cash and cash equivalents | ( | |||||||
| Cash and cash equivalents, at beginning of period | ||||||||
| Cash and cash equivalents, at end of period | $ | $ | ||||||
| Supplemental Disclosure of Cash Flow Information | ||||||||
| Cash payments for: | ||||||||
| Interest | $ | $ | ||||||
| Income taxes, net of refunds | ||||||||
| March 2025 Form 10-Q | 40 | See Notes to Consolidated Financial Statements | ||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
41 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Cash and due from banks | $ | $ | ||||||
| Interest bearing deposits with banks | ||||||||
| Total Cash and cash equivalents | $ | $ | ||||||
| Restricted cash | $ | $ | ||||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3,5 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4,5 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities—AFS | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3,5 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4,5 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities—AFS | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| March 2025 Form 10-Q | 42 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Commercial real estate | $ | $ | ||||||
Residential real estate | ||||||||
| Securities-based lending and Other loans | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Customer and other receivables (payables), net | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Other sovereign government obligations | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| State and municipal securities | ||||||||
| Beginning balance | $ | $ | ||||||
| Purchases | ||||||||
| Sales | ( | |||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| MABS | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ( | |||||
| Loans and lending commitments | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases and originations | ||||||||
| Sales | ( | ( | ||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ( | |||||
| Corporate and other debt | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases and originations | ||||||||
| Sales | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Corporate equities | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ( | |||||
43 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Investments | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ( | |||||
| Net derivatives: Interest rate | ||||||||
| Beginning balance | $ | ( | $ | ( | ||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ||||||||
| Ending balance | $ | ( | $ | |||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Net derivatives: Credit | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Settlements | ||||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | ( | ||||
| Net derivatives: Foreign exchange | ||||||||
| Beginning balance | $ | $ | ( | |||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases | ||||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Net derivatives: Equity | ||||||||
| Beginning balance | $ | ( | $ | ( | ||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | ( | $ | ( | ||||
| Unrealized gains (losses) | $ | $ | ||||||
| Net derivatives: Commodity and other | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | ( | ||||
| Deposits | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Issuances | ||||||||
| Settlements | ( | ( | ||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Nonderivative trading liabilities | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ( | |||||||
| Purchases | ( | ( | ||||||
| Sales | ||||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Securities sold under agreements to repurchase | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Other secured financings | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ( | |||||||
| Issuances | ||||||||
| Settlements | ( | ( | ||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ( | |||||
| Borrowings | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Issuances | ||||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA | ( | |||||||
| March 2025 Form 10-Q | 44 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
Balance / Range (Average1) | ||||||||
| $ in millions, except inputs | At March 31, 2025 | At December 31, 2024 | ||||||
| Assets at Fair Value on a Recurring Basis | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| MABS | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| Loans and lending commitments | $ | $ | ||||||
| Margin loan model: | ||||||||
| Margin loan rate | ||||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Corporate and other debt | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| Corporate equities | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Investments | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| WACC | ||||||||
| Exit multiple | ||||||||
| Market approach: | ||||||||
| EBITDA multiple | ||||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Net derivative and other contracts: | ||||||||
| Interest rate | $ | ( | $ | ( | ||||
| Option model: | ||||||||
| IR volatility skew | ||||||||
| IR curve correlation | ||||||||
| Bond volatility | ||||||||
| Inflation volatility | ||||||||
| Credit | $ | $ | ||||||
| Credit default swap model: | ||||||||
Cash-synthetic basis | ||||||||
| Bond price | ||||||||
| Credit spread | ||||||||
| Funding spread | ||||||||
Foreign exchange2 | $ | $ | ||||||
| Option model: | ||||||||
| IR curve | ||||||||
| Contingency probability | ||||||||
Balance / Range (Average1) | ||||||||
| $ in millions, except inputs | At March 31, 2025 | At December 31, 2024 | ||||||
Equity2 | $ | ( | $ | ( | ||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| FX correlation | - | - | ||||||
| IR correlation | N/M | |||||||
| Commodity and other | $ | $ | ||||||
| Option model: | ||||||||
| Forward power price | $ | $ | ||||||
| Commodity volatility | ||||||||
| Cross-commodity correlation | ||||||||
| Liabilities Measured at Fair Value on a Recurring Basis | ||||||||
| Securities sold under agreements to repurchase | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| Funding spread | ||||||||
| Other secured financings | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Borrowings | $ | $ | ||||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| Equity - FX correlation | - | - | ||||||
| Credit default swap model: | ||||||||
| Credit spread | ||||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| Nonrecurring Fair Value Measurement | ||||||||
| Loans | $ | $ | ||||||
| Corporate loan model: | ||||||||
| Credit spread | ||||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Warehouse model: | ||||||||
| Credit spread | ||||||||
45 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Carrying Value | Commitment | Carrying Value | Commitment | ||||||||||
| Private equity and other | $ | $ | $ | $ | ||||||||||
| Real estate | ||||||||||||||
Hedge | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Carrying Value at March 31, 2025 | ||||||||
| $ in millions | Private Equity and Other | Real Estate | ||||||
| Less than 5 years | $ | $ | ||||||
| 5-10 years | ||||||||
| Over 10 years | ||||||||
| Total | $ | $ | ||||||
| At March 31, 2025 | |||||||||||
| Fair Value | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | $ | $ | $ | ||||||||
| Other assets—Other investments | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| Fair Value | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | $ | $ | $ | ||||||||
| Other assets—Other investments | |||||||||||
| Other assets—ROU assets | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Assets | ||||||||
Loans2 | $ | $ | ( | |||||
Other assets—Other investments3 | ( | |||||||
Other assets—Premises, equipment and software4 | ( | |||||||
| Total | $ | $ | ( | |||||
| Liabilities | ||||||||
Other liabilities and accrued expenses—Lending commitments2 | $ | ( | $ | |||||
| Total | $ | ( | $ | |||||
| March 2025 Form 10-Q | 46 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
| Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1 | |||||||||||||||||
| Held for investment | |||||||||||||||||
| Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments2 | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
| Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1 | |||||||||||||||||
Held for investment | |||||||||||||||||
Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments2 | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Business Unit Responsible for Risk Management | ||||||||
| Equity | $ | $ | ||||||
| Interest rates | ||||||||
| Commodities | ||||||||
| Credit | ||||||||
| Foreign exchange | ||||||||
| Total | $ | $ | ||||||
47 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | Trading Revenues | Interest Expense | Net Revenues1 | ||||||||
| Three Months Ended March 31, 2025 | |||||||||||
| Borrowings | $ | ( | $ | $ | ( | ||||||
| Deposits | ( | ( | |||||||||
| Three Months Ended March 31, 2024 | |||||||||||
| Borrowings | $ | ( | $ | $ | ( | ||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| $ in millions | Trading Revenues | OCI | Trading Revenues | OCI | ||||||||||
Loans and other receivables1 | $ | ( | $ | $ | $ | |||||||||
| Lending commitments | ( | ( | ||||||||||||
| Deposits | ( | |||||||||||||
| Borrowings | ( | ( | ( | |||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Cumulative pre-tax DVA gain (loss) recognized in AOCI | $ | ( | $ | ( | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Loans and other receivables2 | $ | $ | ||||||
Nonaccrual loans2 | ||||||||
Borrowings3 | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Nonaccrual loans | $ | $ | ||||||
| Nonaccrual loans 90 or more days past due | ||||||||
| Assets at March 31, 2025 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Liabilities at March 31, 2025 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading liabilities | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | |||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | ||||||||||||||
48 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Assets at December 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Liabilities at December 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading liabilities | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | |||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Assets at March 31, 2025 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Liabilities at March 31, 2025 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Assets at December 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
49 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Liabilities at December 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Fair value hedges—Recognized in Interest income | ||||||||
| Interest rate contracts | $ | ( | $ | |||||
| Investment Securities—AFS | ( | |||||||
| Fair value hedges—Recognized in Interest expense | ||||||||
| Interest rate contracts | $ | $ | ( | |||||
| Deposits | ( | |||||||
| Borrowings | ( | |||||||
| Net investment hedges—Foreign exchange contracts | ||||||||
| Recognized in OCI | $ | ( | $ | |||||
| Forward points excluded from hedge effectiveness testing—Recognized in Interest income | ||||||||
Cash flow hedges—Interest rate contracts1 | ||||||||
| Recognized in OCI | $ | $ | ( | |||||
| Less: Realized gains (losses) (pre-tax) reclassified from AOCI to interest income | ( | ( | ||||||
| Net change in cash flow hedges included within AOCI | ( | |||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Investment Securities—AFS | ||||||||
Amortized cost basis currently or previously hedged1 | $ | $ | ||||||
Basis adjustments included in amortized cost2 | $ | ( | $ | ( | ||||
| Deposits | ||||||||
Carrying amount currently or previously hedged | $ | $ | ||||||
Basis adjustments included in carrying amount2 | $ | $ | ||||||
| Borrowings | ||||||||
Carrying amount currently or previously hedged | $ | $ | ||||||
Basis adjustments included in carrying amount—Outstanding hedges | $ | ( | $ | ( | ||||
Basis adjustments included in carrying amount—Terminated hedges | $ | ( | $ | ( | ||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Recognized in Other revenues | ||||||||
Credit contracts1 | $ | ( | $ | ( | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Net derivative liabilities with credit risk-related contingent features | $ | $ | ||||||
| Collateral posted | ||||||||
| $ in millions | At March 31, 2025 | ||||
| One-notch downgrade | $ | ||||
| Two-notch downgrade | |||||
Bilateral downgrade agreements included in the amounts above1 | $ | ||||
| March 2025 Form 10-Q | 50 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Years to Maturity at March 31, 2025 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| Years to Maturity at December 31, 2024 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Single-name CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Index and basket CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Total CDS sold | $ | $ | ||||||
| Other credit contracts | ||||||||
| Total credit protection sold | $ | $ | ||||||
| Notional | ||||||||
| $ in billions | At March 31, 2025 | At December 31, 2024 | ||||||
| Single name | $ | $ | ||||||
| Index and basket | ||||||||
| Tranched index and basket | ||||||||
| Total | $ | $ | ||||||
| Fair Value Asset (Liability) | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Single name | $ | ( | $ | ( | ||||
| Index and basket | ( | ( | ||||||
| Tranched index and basket | ( | ( | ||||||
| Total | $ | ( | $ | ( | ||||
51 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | ||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
Unallocated basis adjustment4 | — | — | ||||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | ||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
Unallocated basis adjustment4 | ( | — | — | |||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||
| U.S. Treasury securities | ||||||||||||||
| Less than 12 months | $ | $ | $ | $ | ||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| U.S. agency securities | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Agency CMBS | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| State and municipal securities | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| FFELP student loan ABS | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Total AFS securities in an unrealized loss position | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| March 2025 Form 10-Q | 52 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2,3 | ||||||||
| AFS securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | $ | $ | % | ||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| State and municipal securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 Years | % | ||||||||||
| Total | |||||||||||
| FFELP student loan ABS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
Unallocated basis adjustment4 | — | — | |||||||||
| Total AFS securities | $ | $ | % | ||||||||
| At March 31, 2025 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2 | ||||||||
| HTM securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | $ | $ | % | ||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Non-agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Total HTM securities | $ | $ | % | ||||||||
| Total investment securities | $ | $ | % | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Gross realized gains | $ | $ | ||||||
| Gross realized (losses) | ||||||||
Total1 | $ | $ | ||||||
53 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
| Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
| Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities— Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities— Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Securities sold under agreements to repurchase | ||||||||
| U.S. Treasury and agency securities | $ | $ | ||||||
| Other sovereign government obligations | ||||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Securities loaned | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total included in the offsetting disclosure | $ | $ | ||||||
| Trading liabilities—Obligation to return securities received as collateral | ||||||||
| Corporate equities | $ | $ | ||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Trading assets | $ | $ | ||||||
| March 2025 Form 10-Q | 54 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Collateral received with right to sell or repledge | $ | $ | ||||||
Collateral that was sold or repledged1 | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Segregated securities1 | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Margin and other lending | $ | $ | ||||||
| At March 31, 2025 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Fixed Rate | Floating or Adjustable Rate | Fixed Rate | Floating or Adjustable Rate | ||||||||||
| Corporate | $ | $ | $ | $ | ||||||||||
| Secured lending facilities | ||||||||||||||
| Commercial real estate | ||||||||||||||
| Residential real estate | ||||||||||||||
Securities-based lending and Other | ||||||||||||||
| Total loans, before ACL | $ | $ | $ | $ | ||||||||||
55 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Corporate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Secured Lending Facilities | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Commercial Real Estate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2025 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2025 | ||||||||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
| Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| At December 31, 2024 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| At March 31, 2025 | ||||||||||||||
Securities-based lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
| Revolving | $ | $ | $ | $ | ||||||||||
| 2025 | ||||||||||||||
| 2024 | ||||||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| At December 31, 2024 | ||||||||||||||
Securities-based lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
| Revolving | $ | $ | $ | $ | ||||||||||
| 2024 | ||||||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Commercial real estate | $ | $ | ||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Corporate | $ | $ | ||||||
| Secured lending facilities | ||||||||
| Commercial real estate | ||||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
Total | $ | $ | ||||||
| Nonaccrual loans without an ACL | $ | $ | ||||||
| March 2025 Form 10-Q | 56 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| $ in millions | Amortized Cost | % of Total Loans2 | Amortized Cost | % of Total Loans2 | |||||||||||||
Term Extension | |||||||||||||||||
| Corporate | $ | % | $ | % | |||||||||||||
| Secured lending facilities | % | % | |||||||||||||||
| Commercial real estate | % | % | |||||||||||||||
| Securities-based lending and Other | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Other-than-insignificant Payment Delay | |||||||||||||||||
| Securities-based lending and Other | $ | % | $ | % | |||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay | |||||||||||||||||
| Commercial real estate | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Total Modifications | $ | % | $ | % | |||||||||||||
Three Months Ended March 31, 20251 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Secured lending facilities | % | |||||||||||||
| Commercial real estate | % | |||||||||||||
| Securities-based lending and Other | % | |||||||||||||
Three Months Ended March 31, 20241 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Commercial real estate | % | |||||||||||||
| Securities-based lending and Other | % | |||||||||||||
| Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay | ||||||||||||||
| Commercial real estate | $ | % | ||||||||||||
| At March 31, 2025 | |||||||||||
| $ in millions | 30-89 Days Past Due | 90+ Days Past Due | Total | ||||||||
| Commercial real estate | $ | $ | $ | ||||||||
| At March 31, 2024 | |||||||||||
| $ in millions | 30-89 Days Past Due | 90+ days Past Due | Total | ||||||||
| Commercial real estate | $ | $ | $ | ||||||||
| Three Months Ended March 31, 2025 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Gross charge-offs | ( | ( | ||||||||||||||||||
| Recoveries | ||||||||||||||||||||
Net (charge-offs)/ recoveries | ( | ( | ||||||||||||||||||
| Provision (release) | ||||||||||||||||||||
| Other | ( | |||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
| ACL—Lending commitments | ||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | |||||||||||||||||||
| Other | ||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
57 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, 2024 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | ( | ( | |||||||||||||||||
| Other | ( | ( | ( | ( | ( | |||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
| ACL—Lending commitments | ||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | ( | ( | |||||||||||||||||
| Other | ( | ( | ( | |||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Three Months Ended March 31, 2025 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| 2022 | $ | ( | $ | $ | $ | ( | ||||||||||||||
| 2021 | ( | ( | ||||||||||||||||||
Prior | ( | ( | ||||||||||||||||||
Total | $ | $ | $ | ( | $ | $ | $ | ( | ||||||||||||
| At March 31, 2025 | At December 31, 2024 | |||||||
| ACL for loans to total HFI loans | % | % | ||||||
Nonaccrual HFI loans to total HFI loans | % | % | ||||||
ACL for loans to nonaccrual HFI loans | % | % | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Currently employed by the Firm1 | $ | $ | ||||||
No longer employed by the Firm2 | ||||||||
| Employee loans | $ | $ | ||||||
| ACL | ( | ( | ||||||
| Employee loans, net of ACL | $ | $ | ||||||
| Remaining repayment term, weighted average in years | 5.6 | |||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Investments | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Income (loss) | $ | $ | ||||||
| March 2025 Form 10-Q | 58 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Income (loss) from investment in MUMSS | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Low-income housing | $ | $ | ||||||
Renewable energy and other | ||||||||
Total1,2 | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| $ | $ | |||||||
| ( | ( | |||||||
| $ | $ | |||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Savings and demand deposits | $ | $ | ||||||
| Time deposits | ||||||||
| Total | $ | $ | ||||||
| Deposits subject to FDIC insurance | $ | $ | ||||||
| Deposits not subject to FDIC insurance | $ | $ | ||||||
| $ in millions | At March 31, 2025 | ||||
| 2025 | $ | ||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| Thereafter | |||||
| Total | $ | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Original maturities of one year or less | $ | $ | ||||||
| Original maturities greater than one year | ||||||||
| Senior | $ | $ | ||||||
| Subordinated | ||||||||
| Total greater than one year | $ | $ | ||||||
| Total | $ | $ | ||||||
Weighted average stated maturity, in years1 | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Original maturities: | ||||||||
| One year or less | $ | $ | ||||||
| Greater than one year | ||||||||
| Total | $ | $ | ||||||
| Transfers of assets accounted for as secured financings | $ | $ | ||||||
59 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Years to Maturity at March 31, 2025 | |||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Lending: | |||||||||||||||||
| Corporate | $ | $ | $ | $ | $ | ||||||||||||
| Secured lending facilities | |||||||||||||||||
| Commercial and Residential real estate | |||||||||||||||||
| Securities-based lending and Other | |||||||||||||||||
Forward-starting secured financing receivables1 | |||||||||||||||||
| Central counterparty | |||||||||||||||||
| Underwriting | |||||||||||||||||
| Investment activities | |||||||||||||||||
| Letters of credit and other financial guarantees | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Lending commitments participated to third parties | $ | ||||||||||||||||
| At March 31, 2025 | ||||||||||||||||||||
Maximum Potential Payout/Notional of Obligations by Years to Maturity | Carrying Amount Asset (Liability) | |||||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | ||||||||||||||||
Non-credit derivatives1 | $ | $ | $ | $ | $ | ( | ||||||||||||||
Standby letters of credit and other financial guarantees issued2,3 | ||||||||||||||||||||
| Liquidity facilities | ||||||||||||||||||||
| Whole loan sales guarantees | ||||||||||||||||||||
Securitization representations and warranties4 | ||||||||||||||||||||
| General partner guarantees | ( | |||||||||||||||||||
| Client clearing guarantees | ||||||||||||||||||||
| March 2025 Form 10-Q | 60 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
61 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| March 2025 Form 10-Q | 62 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | VIE Assets | VIE Liabilities | VIE Assets | VIE Liabilities | ||||||||||
MABS1 | $ | $ | $ | $ | ||||||||||
Investment vehicles2 | ||||||||||||||
| MTOB | ||||||||||||||
| Other | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
63 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Trading assets at fair value | ||||||||
| Investment securities | ||||||||
| Customer and other receivables | ||||||||
| Other assets | ||||||||
| Total | $ | $ | ||||||
| Liabilities | ||||||||
| Trading liabilities at fair value | $ | $ | ||||||
| Other secured financings | $ | $ | ||||||
| Other liabilities and accrued expenses | ||||||||
| Borrowings | ||||||||
| Total | $ | $ | ||||||
| Noncontrolling interests | $ | $ | ||||||
| At March 31, 2025 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Carrying value of variable interests—Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Carrying value of variable interests–Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
| March 2025 Form 10-Q | 64 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | UPB | Debt and Equity Interests | UPB | Debt and Equity Interests | ||||||||||
| Residential mortgages | $ | $ | $ | $ | ||||||||||
| Commercial mortgages | ||||||||||||||
| U.S. agency collateralized mortgage obligations | ||||||||||||||
| Other consumer or commercial loans | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| At March 31, 2025 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2,3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2,3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| Fair Value At March 31, 2025 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
| Fair Value At December 31, 2024 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
New transactions1 | $ | $ | ||||||
| Retained interests | ||||||||
65 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Gross cash proceeds from sale of assets1 | $ | $ | ||||||
| Fair value | ||||||||
| Assets sold | $ | $ | ||||||
| Derivative assets recognized in the balance sheet | ||||||||
| Derivative liabilities recognized in the balance sheet | ||||||||
At March 31, 2025 and December 31, 2024 | ||||||||
| Standardized | Advanced | |||||||
| Capital buffers | ||||||||
| Capital conservation buffer | — | |||||||
| SCB | N/A | |||||||
| G-SIB capital surcharge | ||||||||
CCyB1 | ||||||||
| Capital buffer requirement | ||||||||
| Regulatory Minimum | At March 31, 2025 and December 31, 2024 | ||||||||||
| Standardized | Advanced | ||||||||||
Required ratios1 | |||||||||||
CET1 capital ratio | % | ||||||||||
| Tier 1 capital ratio | % | ||||||||||
| Total capital ratio | % | ||||||||||
| March 2025 Form 10-Q | 66 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Standardized | ||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
Risk-based capital | ||||||||
| CET1 capital | $ | $ | ||||||
| Tier 1 capital | ||||||||
| Total capital | ||||||||
| Total RWA | ||||||||
| Risk-based capital ratio | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
Required ratio1 | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Leveraged-based capital | ||||||||
Adjusted average assets1 | $ | $ | ||||||
Supplementary leverage exposure2 | ||||||||
| Leveraged-based capital ratio | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
Required ratio3 | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
| Well-Capitalized Requirement | Required Ratio1 | At March 31, 2025 | At December 31, 2024 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
| CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| Well-Capitalized Requirement | Required Ratio1 | At March 31, 2025 | At December 31, 2024 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
| CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Net capital | $ | $ | ||||||
| Excess net capital | ||||||||
67 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Shares Outstanding | Carrying Value | |||||||||||||
| $ in millions, except per share data | At March 31, 2025 | Liquidation Preference per Share | At March 31, 2025 | At December 31, 2024 | ||||||||||
| Series | ||||||||||||||
| A | $ | $ | $ | |||||||||||
C1 | ||||||||||||||
| E | ||||||||||||||
| F | ||||||||||||||
| I | ||||||||||||||
| K | ||||||||||||||
| L | ||||||||||||||
| M | ||||||||||||||
| N | ||||||||||||||
| O | ||||||||||||||
| P | ||||||||||||||
Q | ||||||||||||||
| Total | $ | $ | ||||||||||||
| Shares authorized | ||||||||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Repurchases of common stock under the Firm’s Share Repurchase Authorization | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| in millions | 2025 | 2024 | ||||||
| Weighted average common shares outstanding, basic | ||||||||
| Effect of dilutive RSUs and PSUs | ||||||||
| Weighted average common shares outstanding and common stock equivalents, diluted | ||||||||
| Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS) | ||||||||
| March 2025 Form 10-Q | 68 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions, except per share data | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||
Per Share1 | Total | Per Share1 | Total | |||||||||||
| Preferred stock series | ||||||||||||||
| A | $ | $ | $ | $ | ||||||||||
| C | ||||||||||||||
| E | ||||||||||||||
| F | ||||||||||||||
| I | ||||||||||||||
| K | ||||||||||||||
| L | ||||||||||||||
M2 | ||||||||||||||
N | ||||||||||||||
| O | ||||||||||||||
| P | ||||||||||||||
| Q | ||||||||||||||
| Total Preferred stock | $ | $ | ||||||||||||
| Common stock | $ | $ | $ | $ | ||||||||||
| $ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
| December 31, 2024 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| OCI during the period | ||||||||||||||||||||
| March 31, 2025 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| December 31, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| OCI during the period | ( | ( | ( | ( | ||||||||||||||||
| March 31, 2024 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| $ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
| CTA | |||||||||||||||||
| OCI activity | $ | $ | $ | $ | $ | ||||||||||||
| Reclassified to earnings | |||||||||||||||||
| Net OCI | $ | $ | $ | $ | $ | ||||||||||||
| Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ( | ( | ||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Pension and other | |||||||||||||||||
| OCI activity | $ | $ | $ | $ | $ | ||||||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Change in net DVA | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Change in fair value of cash flow hedge derivatives | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| $ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
| CTA | |||||||||||||||||
| OCI activity | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||
| Reclassified to earnings | |||||||||||||||||
| Net OCI | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||
| Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ( | ( | ||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Pension and other | |||||||||||||||||
| OCI activity | $ | $ | $ | $ | $ | ||||||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Change in net DVA | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Change in fair value of cash flow hedge derivatives | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
69 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Interest income | ||||||||
Cash and cash equivalents | $ | |||||||
| Investment securities | ||||||||
| Loans | ||||||||
Securities purchased under agreements to resell1 | ||||||||
Securities borrowed2 | ||||||||
| Trading assets, net of Trading liabilities | ||||||||
Customer receivables and Other | ||||||||
| Total interest income | $ | $ | ||||||
| Interest expense | ||||||||
| Deposits | $ | $ | ||||||
| Borrowings | ||||||||
Securities sold under agreements to repurchase3 | ||||||||
Securities loaned4 | ||||||||
Customer payables and Other5 | ||||||||
| Total interest expense | $ | $ | ||||||
| Net interest | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Customer and other receivables | $ | $ | ||||||
| Customer and other payables | ||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ( | |||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1,2 | ( | ||||||||||||||||
| Other | ( | ||||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
| Interest income | ( | ||||||||||||||||
| Interest expense | ( | ||||||||||||||||
| Net interest | ( | ||||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | |||||||||||||||||
Compensation and benefits3 | |||||||||||||||||
Non-compensation expenses3 | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | ( | ||||||||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
Pre-tax margin4 | % | % | % | N/M | % | ||||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1,2 | ( | ||||||||||||||||
| Other | ( | ||||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
Interest income | ( | ||||||||||||||||
Interest expense | ( | ||||||||||||||||
| Net interest | ( | ( | |||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | ( | ( | |||||||||||||||
Compensation and benefits3 | |||||||||||||||||
Non-compensation expenses3 | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | ( | ||||||||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
Pre-tax margin4 | % | % | % | N/M | % | ||||||||||||
| March 2025 Form 10-Q | 70 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Institutional Securities Advisory | $ | $ | ||||||
| Institutional Securities Underwriting | ||||||||
| Firm Investment banking revenues from contracts with customers | % | % | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Interest rate | $ | $ | ||||||
| Foreign exchange | ||||||||
Equity1 | ||||||||
| Commodity and other | ||||||||
| Credit | ( | ( | ||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Net cumulative unrealized performance-based fees at risk of reversing | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Fee waivers | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Transaction taxes | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Americas | $ | $ | ||||||
| EMEA | ||||||||
| Asia | ||||||||
| Total | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2025 | 2024 | ||||||
| Non-interest revenues | $ | $ | ||||||
71 | March 2025 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Customer and other receivables | $ | $ | ||||||
| $ in millions | At March 31, 2025 | At December 31, 2024 | ||||||
| Institutional Securities | $ | $ | ||||||
| Wealth Management | ||||||||
| Investment Management | ||||||||
Total1 | $ | $ | ||||||
| March 2025 Form 10-Q | 72 | |||||||
| Three Months Ended March 31, | ||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||
| $ in millions | Average Daily Balance | Interest | Annualized Average Rate | Average Daily Balance | Interest | Annualized Average Rate | ||||||||||||||
| Interest earning assets | ||||||||||||||||||||
Cash and cash equivalents: | ||||||||||||||||||||
U.S. | $ | 55,223 | $ | 447 | 3.3 | % | $ | 52,696 | $ | 633 | 4.8 | % | ||||||||
Non-U.S. | 42,083 | 212 | 2.0 | % | 43,661 | 270 | 2.5 | % | ||||||||||||
Investment securities1 | 158,395 | 1,280 | 3.3 | % | 153,866 | 1,197 | 3.1 | % | ||||||||||||
Loans1 | 241,885 | 3,325 | 5.6 | % | 217,921 | 3,305 | 6.1 | % | ||||||||||||
Securities purchased under agreements to resell2: | ||||||||||||||||||||
| U.S. | 66,638 | 2,213 | 13.5 | % | 52,260 | 1,496 | 11.5 | % | ||||||||||||
| Non-U.S. | 41,448 | 1,203 | 11.8 | % | 49,595 | 1,034 | 8.4 | % | ||||||||||||
Securities borrowed3: | ||||||||||||||||||||
| U.S. | 113,539 | 1,048 | 3.7 | % | 108,288 | 1,257 | 4.7 | % | ||||||||||||
| Non-U.S. | 16,125 | 68 | 1.7 | % | 18,835 | 119 | 2.5 | % | ||||||||||||
Trading assets, net of Trading liabilities: | ||||||||||||||||||||
| U.S. | 111,891 | 1,248 | 4.5 | % | 107,970 | 1,175 | 4.4 | % | ||||||||||||
| Non-U.S. | 18,435 | 191 | 4.2 | % | 18,329 | 207 | 4.5 | % | ||||||||||||
Customer receivables and Other: | ||||||||||||||||||||
| U.S. | 60,918 | 2,006 | 13.4 | % | 47,180 | 1,700 | 14.5 | % | ||||||||||||
| Non-U.S. | 16,474 | 507 | 12.5 | % | 17,502 | 537 | 12.3 | % | ||||||||||||
| Total | $ | 943,054 | $ | 13,748 | 5.9 | % | $ | 888,103 | $ | 12,930 | 5.9 | % | ||||||||
| Interest bearing liabilities | ||||||||||||||||||||
Deposits1 | $ | 370,745 | $ | 2,522 | 2.8 | % | $ | 346,946 | $ | 2,476 | 2.9 | % | ||||||||
Borrowings1,4 | 282,999 | 3,018 | 4.3 | % | 251,956 | 3,223 | 5.1 | % | ||||||||||||
Securities sold under agreements to repurchase5,7: | ||||||||||||||||||||
| U.S. | 18,108 | 1,786 | 40.0 | % | 24,410 | 1,221 | 20.1 | % | ||||||||||||
| Non-U.S. | 50,533 | 1,283 | 10.3 | % | 58,316 | 1,181 | 8.1 | % | ||||||||||||
Securities loaned6,7: | ||||||||||||||||||||
| U.S. | 10,093 | 29 | 1.2 | % | 5,790 | 17 | 1.2 | % | ||||||||||||
| Non-U.S. | 6,048 | 227 | 15.2 | % | 8,979 | 207 | 9.3 | % | ||||||||||||
Customer payables and Other8: | ||||||||||||||||||||
| U.S. | 119,309 | 1,776 | 6.0 | % | 124,018 | 1,891 | 6.1 | % | ||||||||||||
| Non-U.S. | 58,052 | 754 | 5.3 | % | 64,756 | 918 | 5.7 | % | ||||||||||||
| Total | $ | 915,887 | $ | 11,395 | 5.0 | % | $ | 885,171 | $ | 11,134 | 5.1 | % | ||||||||
| Net interest income and net interest rate spread | $ | 2,353 | 0.9 | % | $ | 1,796 | 0.8 | % | ||||||||||||
73 | March 2025 Form 10-Q | |||||||
| Glossary of Common Terms and Acronyms | ![]() | ||||
2024 Form 10-K | Annual report on Form 10-K for year ended December 31, 2024 filed with the SEC | ||||
| ABS | Asset-backed securities | ||||
| ACL | Allowance for credit losses | ||||
| AFS | Available-for-sale | ||||
| AML | Anti-money laundering | ||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| AUM | Assets under management or supervision | ||||
| Balance sheet | Consolidated balance sheet | ||||
| BHC | Bank holding company | ||||
| bps | Basis points; one basis point equals 1/100th of 1% | ||||
| Cash flow statement | Consolidated cash flow statement | ||||
| CCAR | Comprehensive Capital Analysis and Review | ||||
| CCyB | Countercyclical capital buffer | ||||
| CDO | Collateralized debt obligation(s), including Collateralized loan obligation(s) | ||||
| CDS | Credit default swaps | ||||
| CECL | Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update | ||||
CET1 | Common Equity Tier 1 | ||||
| CFTC | U.S. Commodity Futures Trading Commission | ||||
| CLN | Credit-linked note(s) | ||||
| CLO | Collateralized loan obligation(s) | ||||
| CMBS | Commercial mortgage-backed securities | ||||
| CMO | Collateralized mortgage obligation(s) | ||||
| CRE | Commercial real estate | ||||
| CRM | Credit Risk Management Department | ||||
| CTA | Cumulative foreign currency translation adjustments | ||||
| DCP | Employee deferred cash-based compensation plans linked to investment performance | ||||
| DCP investments | Investments associated with certain DCP | ||||
| DVA | Debt valuation adjustment | ||||
| EBITDA | Earnings before interest, taxes, depreciation and amortization | ||||
| EMEA | Europe, Middle East and Africa | ||||
| EPS | Earnings per common share | ||||
| FDIC | Federal Deposit Insurance Corporation | ||||
| FFELP | Federal Family Education Loan Program | ||||
| FHC | Financial holding company | ||||
| FICO | Fair Isaac Corporation | ||||
| Financial statements | Consolidated financial statements | ||||
| FVO | Fair value option | ||||
| G-SIB | Global systemically important bank | ||||
| HFI | Held-for-investment | ||||
| HFS | Held-for-sale | ||||
| HQLA | High-quality liquid assets | ||||
| HTM | Held-to-maturity | ||||
| I/E | Intersegment eliminations | ||||
| IHC | Intermediate holding company | ||||
| IM | Investment Management | ||||
| Income statement | Consolidated income statement | ||||
| IRS | Internal Revenue Service | ||||
| IS | Institutional Securities | ||||
| LCR | Liquidity coverage ratio, as adopted by the U.S. banking agencies | ||||
| LTV | Loan-to-value | ||||
| M&A | Merger, acquisition and restructuring transaction | ||||
| MSBNA | Morgan Stanley Bank, N.A. | ||||
| MS&Co. | Morgan Stanley & Co. LLC | ||||
| MSCG | Morgan Stanley Capital Group Inc. | ||||
| MSCS | Morgan Stanley Capital Services LLC | ||||
| MSESE | Morgan Stanley Europe SE | ||||
| MSIP | Morgan Stanley & Co. International plc | ||||
| MSMS | Morgan Stanley MUFG Securities Co., Ltd. | ||||
| MSPBNA | Morgan Stanley Private Bank, National Association | ||||
| MSSB | Morgan Stanley Smith Barney LLC | ||||
| MUFG | Mitsubishi UFJ Financial Group, Inc. | ||||
| MUMSS | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | ||||
| MWh | Megawatt hour | ||||
| N/A | Not Applicable | ||||
| N/M | Not Meaningful | ||||
| NAV | Net asset value | ||||
| Non-GAAP | Non-generally accepted accounting principles in the U.S. | ||||
| NSFR | Net stable funding ratio, as adopted by the U.S. banking agencies | ||||
| OCC | Office of the Comptroller of the Currency | ||||
| OCI | Other comprehensive income (loss) | ||||
| OTC | Over-the-counter | ||||
| PSU | Performance-based stock unit | ||||
| ROE | Return on average common equity | ||||
| ROTCE | Return on average tangible common equity | ||||
| ROU | Right-of-use | ||||
| RSU | Restricted stock unit | ||||
| RWA | Risk-weighted assets | ||||
| SCB | Stress capital buffer | ||||
| SEC | U.S. Securities and Exchange Commission | ||||
| SLR | Supplementary leverage ratio | ||||
| S&P | Standard & Poor’s | ||||
| SPE | Special purpose entity | ||||
| SPOE | Single point of entry | ||||
| TLAC | Total loss-absorbing capacity | ||||
| U.K. | United Kingdom | ||||
| UPB | Unpaid principal balance | ||||
| U.S. | United States of America | ||||
| U.S. Bank Subsidiaries | MSBNA and MSPBNA | ||||
| U.S. GAAP | Accounting principles generally accepted in the U.S. | ||||
| VaR | Value-at-Risk | ||||
| VIE | Variable interest entity | ||||
| WACC | Implied weighted average cost of capital | ||||
| WM | Wealth Management | ||||
| March 2025 Form 10-Q | 74 | |||||||
| $ in millions, except per share data | Total Number of Shares Purchased1 | Average Price Paid per Share2 | Total Shares Purchased as Part of Share Repurchase Authorization2,3 | Dollar Value of Remaining Authorized Repurchase | ||||||||||
| January | 7,818,953 | $ | 136.00 | 1,115,300 | $ | 18,347 | ||||||||
| February | 3,124,925 | $ | 135.90 | 2,378,100 | $ | 18,023 | ||||||||
| March | 4,594,211 | $ | 117.94 | 4,450,384 | $ | 17,500 | ||||||||
| Three Months Ended March 31, 2025 | 15,538,089 | $ | 130.64 | 7,943,784 | ||||||||||
| Exhibit No. | Description | ||||
| 15 | |||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1 | |||||
| 32.2 | |||||
| 101 | Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”). | ||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). | ||||
MORGAN STANLEY (Registrant) | |||||
| By: | /s/ SHARON YESHAYA | ||||
| Sharon Yeshaya Executive Vice President and Chief Financial Officer | |||||
| By: | /s/ RAJA J. AKRAM | ||||
| Raja J. Akram Deputy Chief Financial Officer, Chief Accounting Officer and Controller | |||||
75 | March 2025 Form 10-Q | |||||||